Study of the Yeast Cell Wall Components, Mannan Oligosaccharide and Beta Glucan, to Determine Their Individual and Synergistic Influence on Broiler Performance Under Pathologic Stress by Hashim, Mohammed Malik
  
 
 
STUDY OF THE YEAST CELL WALL COMPONENTS, MANNAN 
OLIGOSACCHARIDE AND BETA GLUCAN, TO DETERMINE THEIR 
INDIVIDUAL AND SYNERGISTIC INFLUENCE ON BROILER 
PERFORMANCE UNDER PATHOLOGIC STRESS 
 
A Dissertation 
by 
  MOHAMMED MALIK HASHIM  
 
Submitted to the Office of Graduate and Professional Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY 
 
 
Chair of Committee,  Christopher A. Bailey  
Committee Members, Christine Z. Alvarado 
 Luc R. Berghman 
 James Allen Byrd 
Head of Department, David J. Caldwell 
 
August 2016 
 
Major Subject: Poultry Science 
 
Copyright 2016 Mohammed Malik Hashim
 ii 
 
ABSTRACT 
 
Different supplementations or strategies have been proposed as alternatives to the 
use of antibiotics at sub-therapeutic levels in chickens. Mannan oligosaccharides (MOS) 
and β-glucans have been reported to beneficially influence broiler performance and 
health. However, different purifications levels have been employed to investigate the 
efficacy of those oligosaccharides, and thus conflicts have been noticed with respect to 
their influences.  
A series of studies were conducted to investigate the influence of purification, 
source, and individual components of yeast cell wall (YCW) on broiler performance 
subjected to pathogenic challenge. The challenge model included administration of 10x 
the recommended level of infectious bursal disease vaccine via the ocular route to all 
birds on day 10, in order to immunocompromise them. On days 16 and 17, birds in all 
treatments except non-challenged control received 3 mL of 107 cfu of Clostridium 
perfringens (Cp). Broiler performance was evaluated on days 10, 16, and 21. In study 1, 
tissue samples were collected from the jejunum and duodenum regions for analysis with 
a chicken-specific peptide arrays technique to study the influence of YCW 
supplementation on the immune and metabolic pathways.  
The Cp challenge significantly impacted broiler performance in all studies. The 
purification level of YCW preparations had different levels of influence on performance 
as well as metabolic pathways. The addition of purified YCW to the starter broiler diets 
improved performance and influenced the immune and metabolic pathways in the gut.  
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In the second study, two experiments were conducted with different levels of 
highly purified β-glucan from algae (Euglena gracilis) or highly purified MOS from 
Saccharomyces cerevisiae. Addition of no more than 30 ppm of algae β-glucan was 
sufficient to improve broiler performance; however, no significant differences were 
observed in performance with any of the MOS levels.  
The third study evaluated the influence of mannoproteins or β-glucan 
preparations purified at 50-55%, derived from the same YCW product of Saccharomyces 
cerevisiae individually or in combination. The performance of starter broilers was 
improved when a combination of mannoprotein and β-glucan was added to the diet.  
The last study evaluated the influence of two YCW products prepared from two 
different strains of Saccharomyces cerevisiae on full-term broiler performance for birds 
reared on reused floor litter. The products were supplemented at either 250 ppm 
continuously or 500, 250, and 125 ppm in the starter, grower, and finisher phases, 
respectively. Broiler performance positively responded to YCW products and both 
feeding strategies. Overall, purification and source of β-glucan and MOS have 
significant impacts on broiler response, and those components have synergetic influence 
when combined.     
 iv 
 
DEDICATION 
 
This work is dedicated to my parents, Mr. Malik Hashim and Mrs. Fadheelah 
Ibrahim.  
 
 
 v 
 
ACKNOWLEDGEMENTS 
 
I would like to thank my committee chair, Dr. Christopher Bailey, for his 
unlimited precious advice and support that cannot be fully expressed with these words. I 
extend my appreciation to my committee members, Dr. Christine Alvarado, Dr. Luc 
Berghman, and Dr. James Allen Byrd for their guidance and support throughout the 
course of this research. 
I also want to extend my gratitude to Dr. Michael H. Kogut at the Southern 
Plains Agricultural Research Center in the Agricultural Research Service of the United 
States Department of Agriculture and Dr. Ryan J. Arsenault at the Department of Animal 
and Food Sciences at the University of Delaware for their dedicated help and work to 
perform the chicken-specific peptide arrays study.  
I also would like to extend my appreciation to Mrs. Denise Y. Caldwell at the 
Southern Plains Agricultural Research Center in the Agricultural Research Service of the 
United States Department of Agriculture. Gratitude is also extended to Dr. Akram-ul 
Haq and my lab partners Morouj Al-Ajeeli, Raghad Abduljaleel, Akhil Alsadwi, Justin 
Fowler, Hector Leyva-Jimenez and Yasser Jamal Jameel. Thanks also go to my friends 
and colleagues and the department faculty and staff for making my time at Texas A&M 
University a great experience. 
 vi 
 
NOMENCLATURE 
 
AGP Antibiotic Growth Promoter 
AMPK 5'-Adenosine Monophosphate-activated Protein Kinase 
BG β-glucan 
Cp Clostridium perfringens  
mTOR mammalian target of rapamycin 
MOS Mannan oligosaccharides  
NE Necrotic Enteritis  
NK cells Natural Killer cells  
YCW Yeast Cell Wall 
 
 vii 
 
TABLE OF CONTENTS 
                                                                                                                                   Page 
 
ABSTRACT .......................................................................................................................ii 
DEDICATION .................................................................................................................. iv 
ACKNOWLEDGEMENTS ............................................................................................... v 
NOMENCLATURE .......................................................................................................... vi 
TABLE OF CONTENTS .................................................................................................vii 
LIST OF FIGURES ............................................................................................................ x 
LIST OF TABLES ............................................................................................................ xi 
CHAPTER I  INTRODUCTION AND LITERATURE REVIEW ................................... 1 
Introduction .................................................................................................................... 1 
Yeast cell wall ............................................................................................................ 1 
Gastrointestinal tract ................................................................................................... 2 
Yeast cell wall as an antibiotic alternative ................................................................. 3 
Kinomics .................................................................................................................... 4 
Literature Review ........................................................................................................... 6 
Saccharomyces cerevisiae .......................................................................................... 6 
Glucans ..................................................................................................................... 13 
Mannoproteins .......................................................................................................... 19 
Clostridium perfringens ........................................................................................... 21 
Chicken-specific peptides arrays .............................................................................. 23 
CHAPTER II INFLUENCE OF DIFFERENT YCW PREPARATIONS AND YCW 
COMPONENTS ON BROILER PERFORMANCE AND METABOLIC 
PATHWAYS .................................................................................................................... 25 
Introduction .................................................................................................................. 25 
Materials and Methods ................................................................................................. 28 
Experimental design ................................................................................................. 28 
Isolation and administration of Clostridium perfringens ......................................... 31 
 viii 
 
Intestinal tissue sampling ......................................................................................... 31 
Chicken-specific peptide arrays ............................................................................... 32 
Statistical analysis .................................................................................................... 33 
Results and Discussion ................................................................................................. 34 
Broiler performance ................................................................................................. 34 
Peptide arrays ........................................................................................................... 40 
CHAPTER III ASSESSEMENT OF ALGAE BETA GLUCAN AND YEAST 
MANNAN ON BROILER PERFORMANCE UNDER CLOSTRIDIUM 
CHALLENGE .................................................................................................................. 47 
Introduction .................................................................................................................. 47 
Materials and Methods ................................................................................................. 50 
Dietary treatments .................................................................................................... 50 
Animal husbandry .................................................................................................... 51 
Statistical analysis .................................................................................................... 53 
Results and Discussion ................................................................................................. 53 
CHAPTER IV INFLUENCES OF SACCHAROMYCES CEREVISIAE-DERIVED Β-
GLUCAN AND MANNAN ON BROILER PERFORMANCE ..................................... 66 
Introduction .................................................................................................................. 66 
Materials and Methods ................................................................................................. 67 
Dietary treatments .................................................................................................... 67 
Animal husbandry .................................................................................................... 68 
Statistical analysis .................................................................................................... 70 
Results and Discussion ................................................................................................. 70 
CHAPTER V  PERFORMANCE OF BROILERS FED DIETS SUPPLEMENTED 
WITH TWO YEAST CELL WALL STRAINS USING TWO FEEDING 
STRATEGIES .................................................................................................................. 77 
Introduction .................................................................................................................. 77 
Materials and Methods ................................................................................................. 78 
Dietary treatments .................................................................................................... 78 
Animal husbandry .................................................................................................... 79 
Statistical analysis .................................................................................................... 79 
Results and Discussion ................................................................................................. 81 
 ix 
 
CHAPTER VI SUMMARY ............................................................................................. 87 
REFERENCES ................................................................................................................. 91 
 
 x 
 
LIST OF FIGURES 
 Page 
Figure 2.1 Dendrogram of peptide arrays comparing similarity in metabolic pathways 
in the duodenum and jejunum of 21 days of age broilers. ................................ 41 
Figure 2.2 Dendrogram of peptide arrays comparing similarity in metabolic pathways 
of mannan oligosaccharides vs challenged control in the duodenum and 
jejunum of 21 days of age broilers. .................................................................. 42 
Figure 3.1 Effect of β-glucan dose on broiler body weight (BW). .................................. 59 
 
 xi 
 
LIST OF TABLES 
 Page 
Table 2.1 Composition and nutrient content of the basal starter diet for the yeast     
cell wall purification study. .............................................................................. 30 
Table 2.2 Effect of yeast cell wall purification on broiler performance on day 10  
(pre-immunocompromised). ............................................................................. 36 
Table 2.3 Effect of yeast cell wall purification on broiler performance on day 16  
(pre-challenge). ................................................................................................. 37 
Table 2.4 Effect of yeast cell wall purification on broiler performance on day 21 
(post-challenge). ............................................................................................... 39 
Table 3.1 Composition and nutrient content of the basal starter diet for algae beta 
glucan and yeast mannan oligosaccharides. ..................................................... 52 
Table 3.2 Effect of algae beta glucan levels on broiler performance on day 10       
(pre-immunocompromised). ............................................................................. 55 
Table 3.3 Effect of algae beta glucan levels on broiler performance on day 16       
(pre-challenge). ................................................................................................. 56 
Table 3.4 Effect of algae beta glucan levels on broiler performance on day 21     
(post-challenge). ............................................................................................... 58 
Table 3.5 Effect of yeast mannan oligosaccharides levels on broiler performance      
on day 10 (pre-immunocompromised). ............................................................ 60 
Table 3.6 Effect of yeast mannan oligosaccharides levels on broiler performance on 
day 16 (pre-challenge). ..................................................................................... 61 
Table 3.7 Effect of yeast mannan oligosaccharides levels on broiler performance on 
day 21 (post-challenge). .................................................................................... 63 
Table 4.1 Composition and nutrient content of the basal starter diet for the yeast 
derived mannoproteins and β-glucan study. ..................................................... 69 
Table 4.2 Effect of yeast cell wall components on broiler performance on day 10  
(pre-immunocompromised). ............................................................................. 71 
Table 4.3 Effect of yeast cell wall components on broiler performance on day 16  
(pre-challenge). ................................................................................................. 72 
 xii 
 
Table 4.4 Effect of yeast cell wall components on broiler performance on day 21 
(post-challenge). ............................................................................................... 74 
Table 5.1 Composition and nutrient content of the experimental basal diets. ................. 80 
Table 5.2 Effect of two different strains of yeast cell wall on broiler performance on 
day 21 (Starter Phase). ...................................................................................... 82 
Table 5.3 Effect of two different strains of yeast cell wall on broiler performance on 
day 35 (Grower phase). ..................................................................................... 84 
Table 5.4 Effect of two different strains of yeast cell wall on broiler performance on 
day 42 (Finisher phase). .................................................................................... 85 
 
 
 
 
 1 
 
CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
Introduction 
Yeast cell wall 
The rigidity of the cell wall maintains the shape of the yeast and provides 
protection to prevent cell rupture due to internal pressure. Yeast cell wall (YCW) has an 
anionic surface and its fibrous composition depends on β-1,3- and β-1,4-linked 
polysaccharides that form helical (β-1,3-glucan) or ribbon-like (chitin and cellulose) 
structures (Lipke and Ovalle, 1998). The cell wall of Saccharomyces cerevisiae 
comprises approximately 15-30 percent of the dry weight of vegetative yeast (Orlean, 
1997). A quantitative chemical analysis revealed that the chemical composition of yeast 
cell wall consists of 3% ash, 13% protein, 8.5% lipid (mostly neutral fat), and two major 
polysaccharides: glucan (29%) and mannan (31%); the latter is associated with protein 
present in the wall to form mannoprotein complexes (Northcote and Horne, 1952). The 
mannan is linked to the protein by N-links, and this complex is attached covalently to a 
short chain β-1,6-glucan by a glycosylphosphatidylinositol anchor protein (Kollár et al., 
1997). Another component of YCW is chitin, which is present in a very negligible 
amount of about 1-2% and mostly occurs in the division septum (Orlean, 1997). The 
composition and/or percent makeup of YCW components are not always constant. The 
ratio of the mannose polymers (mannoproteins) to glucose polymers (β-1,3-glucan and 
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β-1,6-glucan) and chitin in the cell wall seems to be somewhat dependent on the growth 
medium or fermentation conditions (Aguilar-Uscanga and François, 2003).  
Gastrointestinal tract  
 The gastrointestinal tract has important biological functions that include 
digestion of food, secretion of digestive elements, absorption of nutrients, and excretion 
of waste materials. The mucosa of the gastrointestinal tract is the largest mucosal surface 
and is considered a pivotal location for innate and adaptive immune responses because 
of its direct contact with nutritional antigens and various microorganisms (Turner, 2009). 
The mucosal barrier of the GI tract is composed of the extracellular components mucin 
and an unstirred layer, as well as cellular components. Mucins are heavily glycosylated 
proteins that are secreted by specialized mucosal epithelial cells such as goblet cells and 
play a vital role in preventing direct contact between the epithelial layer and microbes 
(Turner, 2009). The epithelial cell plasma membrane also serves as a mucosal barrier, 
thus any direct damage to the epithelial cell causes interruption to the barrier function. 
The apical junction complex, which consists of adherens and tight junctions, regulates 
the function of the paracellular pathway in healthy epithelial cells and a ring of myosin 
and actin (Turner, 2009) reinforces those junctions. Tight junctions are complexes of 
multi-proteins consisting of transmembrane proteins, peripheral membrane proteins, and 
regulatory molecules such as kinases (Turner, 2009). 
The digestive tract is occupied by tremendous amounts of microbiota that can 
produce beneficial or harmful compounds to the host by fermentation processes. This 
microflora can be altered due to environmental or nutritional changes, and such 
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alterations can have physiological or systemic influences on the host. An example of a 
microbe that exists in the gastrointestinal tract is Clostridium perfringens, which is a 
gram positive, spore forming, anaerobic bacilli, and exotoxin and enterotoxin producing 
bacteria. This bacterium is opportunistic and can proliferate rapidly under conditions that 
may not be favorable to the host. It has been linked to clinical or subclinical necrotic 
enteritis and leads to adverse effects on host health and performance. This pathogen 
causes significant economic loss to the U.S. poultry industry. In addition, cases of 
foodborne illness in humans have been linked to this pathogen. The use of antibiotics at 
sub-therapeutic levels as growth promoters has helped in controlling the incidence of 
necrotic enteritis in poultry. However, antibiotic-free poultry products and consumer 
demands toward banning the prophylactic use of antibiotics encourage development of 
antibiotic-free feeds that can help control pathogenic organisms such as Clostridium 
perfringens.  
Yeast cell wall as an antibiotic alternative  
 Gibson and Roberfroid (1995) introduced the concept of prebiotics as 
nondigestible food ingredients that benefit the host by selectively stimulating the growth 
and/or activity of one or a limited number of bacteria in the colon, resulting in improved 
host health. Many compounds have been recognized as prebiotics. Studies have 
demonstrated that YCW is capable of reducing pathogenic colonization and altering 
microbial structure in the gastrointestinal tract (Calveyra et al., 2012; Corrigan et al., 
2011; Spring et al., 2000; Thanissery et al., 2010). Mannan oligosaccharides (MOS), one 
of the main components of YCW, are able to bind to some pathogenic bacteria and thus 
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remove those bacteria from the intestine as well as enhance the immune status of the 
host (Spring et al., 2000). These oligosaccharides have the ability to inhibit the 
attachment of bacteria with Type-1 fimbriae, such as strains of Salmonella and E. coli, to 
the intestinal mucosa (Spring et al., 2000). In addition, YCW has the ability to modify 
the microbial community in the colon and increase the population of some beneficial 
bacteria such as Lactobacillus (Hashim et al., 2013). Glucan has also shown some 
prebiotic activity on some probiotic bacteria as shown in a study by Russo et al. (2012), 
who reported that β-D-glucan positively influenced the growth of Lactobacillus strains 
in vitro.   
Kinomics  
The influence of intestinal microbial system alteration on host performance has 
been studied for many years. The use of YCW or its components as alternative growth 
promotors has proven to alter gut microbiota and enhance animal growth. Studies have 
demonstrated that 5'-adenosine monophosphate-activated protein kinase (AMPK) 
enzyme activity is influenced when there is change in the intestinal microflora via an 
unclear mechanism (Arsenault et al., 2013). Kinases catalyze the hydrolysis of 
phosphate groups from ATP; kinomics is the study of these kinase enzyme groups. 
Several techniques are being used to investigate cellular signaling through 
phosphorylation. The peptide arrays technique is one such technique. As its name 
implies, this procedure uses peptides that represent the target site of kinase enzymes, and 
an array surface is used to synthesize and print these peptides. Then, a mixture of 
purified kinases or a cellular lysate that represent active protein kinases is applied to the 
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array and recognizes their corresponding target sequences. Phosphorylation due to added 
adenosine triphosphate (ATP) is visualized via several methods such as radioactivity, 
antibody phosphorylation, or phosphor-specific stains using fluorescent phosphorylation 
sensor dye (Arsenault and Kogut, 2012).  
Some enzymatic proteins may not catalyze their reaction and influence their 
substrates because of no activating post-translating modification, or due to protein 
sequestering within an organelle (Arsenault and Kogut, 2012). Most signal transductions 
in eukaryotic cells are mediated by protein kinases, which also regulate several cell 
processes including but not limited to metabolism, apoptosis, and cell differentiation. In 
addition, protein phosphorylation is pivotal to intercellular communication during 
development or functioning of the immune system (Manning et al., 2002). The peptide 
array technique focuses on active kinase enzyme sequence rather than complete protein 
sequence because full-length protein is not always stable on an array format (Arsenault 
and Kogut, 2012). Phosphorylated proteins commonly have multiple phosphorylation 
sites and thus have different protein behaviors, such as one site activating enzyme 
catalyst activity and another site deactivating this activity (Arsenault and Kogut, 2012; 
Gottipati et al., 2008; Smith et al., 2009). Therefore, important information can be 
obtained from these phosphorylation activities, and they can be separated from each 
other by printing these specific phosphorylation sites as separated peptides on the array 
(Arsenault and Kogut, 2012). Since phosphorylation controls the cellular signaling 
pathways that regulate metabolism, chicken-specific kinomic techniques can be 
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employed to understand any change in the metabolic process, such as activation or 
deactivation (Diks et al., 2004).      
To the best of our knowledge, there is no comprehensive study that investigates 
the differences between the components of YCW on broiler performance and reveals 
their individual mechanisms of action. In order to better understand the influence and 
mechanism of YCW components on broiler performance, the glucan and mannan 
components will be investigated in a series of experiments. First, the influence of YCW 
purification on broiler performance will be evaluated. In addition, a chicken-specific 
peptide arrays technique will be employed to evaluate the differences in immune and 
metabolic pathways that can be observed due to different purification level or 
component of YCW. Then, separate experiments will be conducted to assess different 
levels of algae β-glucan, and yeast mannan oligosaccharides (MOS) and compare them 
to intact YCW. Third, purified yeast MOS and glucan subcomponents will be compared 
either individually or in combination to YCW. Finally, two different supplementation 
strategies of primary or brewer’s YCW strains will be investigated in broiler floor study. 
     
Literature Review  
Saccharomyces cerevisiae  
 Saccharomyces cerevisiae is a species of yeast and a normal habitant of soil, and 
it can be found associated with fruits and vegetables. It belongs to the fungi kingdom 
because its cell wall contains chitin. The shape of this yeast is ellipsoidal ovoid to round 
and has a diameter of approximately 5-10 micrometers. It reproduces through asexual 
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reproduction known as “budding” and takes about 1.5 hours to divide. It was used in 
beverage fermentation about 9000 years ago by the Chinese and later used by the 
Persians in wine, as well as the ancient Egyptians in bread baking (Anonymous, 2015; 
Legras et al., 2007). In 1856, Luis Pasteur found that this yeast is a facultative anaerobic 
microorganism and has a crucial role in wine making and bread baking processes 
(Anonymous, 2015). 
 Although no toxins have been isolated from Saccharomyces cerevisiae that can 
be harmful to humans or animals, this yeast can produce anti-yeast toxins called killer 
toxins which are classified as proteins or glycoproteins. Phospholipase A and 
lysophospholipase improve the ability of the yeast to attach to the cell wall surface and 
cause colonization to start the yeast infection process. Thus, these enzymes are virulence 
factors that are used to measure the degree of virulence of the yeasts (EPA, 1997). In 
order to consider yeast as nonpathogenic, it should have low phospholipase activity. 
Saccharomyces cerevisiae has the lowest enzyme activity among all other yeasts that 
have been tested and thus is considered as a nonpathogenic yeast (Barrett-Bee et al., 
1985). Ability of yeast to compromise the immune system of the host is another factor 
that is used to determine the virulence of the yeast. Colonization of Saccharomyces 
cerevisiae was greater in animals exposed to this yeast and treated with cortisone as an 
immunosuppressant factor compared with animals exposed to yeast only. However, both 
groups of animals had no illness effects, which suggests that this yeast is nonpathogenic 
(Holzschu et al., 1979). 
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Legras et al. (2007) isolated 651 strains of Saccharomyces cerevisiae that were 
collected from 56 different regions around the world. These strains were grouped into 
three main categories according to their substrates that included wine, bread, and beer, 
and some strains were isolated from fermented milk and cheese. The differentiation 
between these strains is a consequence of technological changes throughout human 
history and genetic drift factors.      
The cell wall of Saccharomyces cerevisiae provides physical and osmotic 
protection and maintains the shape of the yeast (Smith et al., 2000). The wall consists of 
two layers: an outer layer which is electron-dense and consists mainly of mannoproteins, 
and an inner layer which contributes approximately 50-60% of the dry weight of the 
wall, is electron-transparent, provides most of the mechanical support, and consists of β-
1, 3-glucan and chitin (Klis et al., 2002b). The cell wall proteins are connected by 
covalent links to the β-1, 3-glucan and chitin either directly or indirectly via β-1, 6-
glucan (Klis et al., 2002b).   
One of the disadvantages of employing the yeast in the diet is the low 
digestibility of the cell wall, which can be improved via enzymatic hydrolysis and 
decreasing the DNA and RNA volume (Tukmechi and Bandboni, 2014). Production of 
yeast extract is conducted by removing the cell wall of the yeast completely; the final 
product has better digestibility, with higher protein content than either the yeast itself or 
hydrolyzed yeast (Tukmechi and Bandboni, 2014). The extract of Saccharomyces 
cerevisiae has been investigated to study its effects on performance and health of both 
humans and animals. One of those studies examined the influence of the yeast extract 
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added to cosmetic formulation with or without vitamins A, E, and C on skin moisture 
and skin microrelief after 3 hours, 15, and 30 days of application (Gaspar et al., 2008). 
This study found that the yeast extract improved skin brightness, and this treatment or its 
combination with the vitamins prolonged the skin microrelief effect.  
Another study was conducted to evaluate the effect of supplementation of baker’s 
yeast extract and/or hydrolyzed yeast powder on hematological and immunological 
parameters of rainbow trout (Tukmechi and Bandboni, 2014). This study concluded that 
a combination of yeast extract and hydrolyzed yeast powder, each at 0.5%, increased the 
total leukocyte counts, neutrophils, lymphocytes, and monocytes percentages. In 
addition, the combination treatment had significantly higher lysosome activity and total 
antibody levels than all other treatments on days 30 and 60 of the study. While yeast 
extract alone produced a higher antibody level than hydrolyzed powder or control 
treatments on day 30 and only higher than control on day 60, it had higher lysosome 
activity than the control only on day 30 and both treatments alone were higher than 
control on day 60. The findings of this study suggested that a combination of yeast 
extract and hydrolyzed yeast powder improved the health of the rainbow trout. 
In poultry, much research has been conducted to assess the administration of 
yeast extract or YCW on performance and health of different poultry species. The 
encouraging results of these studies increased attention paid to the prospect of using 
these supplements to replace antibiotic growth promoters. One of these studies examined 
the influence of adding 0.1% of a YCW derivative product that contains 26% β-glucan 
and 15% MOS on broiler breeders fed a diet contaminated with 100 ppb aflatoxin 
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(Matur et al., 2011). The study found that yeast wall extract effectively ameliorated the 
negative effects of aflatoxin on heterophil and lymphocyte percentages. Although 
aflatoxin did not negatively affect the phagocytic activity percent, addition of yeast 
extract positively improved this innate immune system variable. Another study was 
conducted to evaluate the effect of yeast extract containing standardized portions of β-
glucan and MOS on body weight, hematologic parameters, and immunologic variables 
of Hybrid Converter turkey poults challenged with E. coli and transportation stress (Huff 
et al., 2010). It was reported that adding yeast extract at 1000 g/ton significantly 
increased body weight of the control group, but not the stressed treatment. The bacterial 
and transportation stresses decreased the total leukocytes count and percentage of 
lymphocytes and increased the heterophils: lymphocytes ratio and heterophils 
percentage, but the changes were not observed in birds fed the supplemented diet. 
Hemoglobin concentration and hematocrit were significantly higher in stressed poults 
fed on diet supplemented with 1000 g/ton than control stressed poults. This finding 
suggested that YCW extract can be used as an immunomodulatory and can be 
considered a developing alternative to antibiotics in turkey. Feeding male broilers a basal 
diet vs diet supplemented with either yeast extract or bacitracin methylene disalicylate 
with or without Clostridium perfringens challenge was also investigated (Thanissery et 
al., 2010). This research trial reported that on the day after challenge, the concentration 
of Clostridium perfringens in the small intestine was significantly lower in birds fed the 
diet with antibiotic (2.09 log10 cfu/g) than the control challenged birds (4.71 log10 cfu/g), 
and the challenged birds fed a diet supplemented with yeast extract had a pathogenic 
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concentration (2.98 log10 cfu/g) comparable to the antibiotic treatment. Yeast extract was 
fed to the birds for the first ten days prior to challenge at 2% of the diet instead of lower 
concentration throughout the study, which could be the reason for not having a 
significant reduction in Clostridium concentration compared to control challenged 
group. YCW extract was also investigated at three different levels throughout the study 
(800, 400, and 200 mg/kg of diet for 10, 14, and 11 days) to examine its efficacy 
compared to antibiotic zinc bacitracin (100 mg/kg of diet10 days and 50 mg/kg of diet 
for 25 days) or antibacterial coccidiostat ionophore salinomycin (60 mg/kg for the entire 
time of the study) on broilers challenged with attenuated vaccine strain sporulated 
oocysts of Eimeria maxima, E. acervulina, and E. brunetti on day 9 and then challenged 
with Clostridium perfringens on day 14 (M'Sadeq et al., 2015). This study reported no 
significant differences in feed intake between challenged treatments that were 
supplemented with YCW extract, salinomycin, or zinc bacitracin on days 24 or 35. 
Although weight gain was significantly higher in salinomycin treatment than both zinc 
bacitracin and yeast extract treatments (which both exhibited the same weight gain 
results), all challenged supplemented treatments were significantly higher than 
challenged control on day 24, diminishing the difference in weight gain among the 
supplemented treatments. Intestinal integrity was positively influenced with yeast cell 
extract via increasing villus height, decreasing crypt depth, and increasing villus height: 
crypt depth ratio in the jejunum, which can explain the improvement in performance in 
those birds. The effect of live heat-stable yeast culture or different sources of its 
derivatives such as baker’s or brewer’s yeast was investigated in series of trials on 
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performance of starter broilers that were subjected to immune stress by infectious bursa 
disease vaccine followed by Clostridium perfringens challenge (Fowler et al., 2015b). 
This group of studies revealed that the origin of YCW product has no effect on broiler 
performance; however, blending baker’s and brewer’s YCW derivatives at 50% each 
with an inclusion rate of 135 ppm improved body weight significantly more than control 
and both yeast derivatives alone. In addition, the dose of YCW affected body weight in a 
quadratic response, and a 250 ppm inclusion rate had a better response than 125 or 500 
ppm.  
Another study was conducted to assess the amelioration effect of adding heat-
stable live yeast culture or YCW extract products to the diet of full-term broilers fed on a 
corn/soy diet or a variable ingredients diets (Fowler et al., 2015a). This study indicated 
that feeding broilers a diet composed of variable ingredients negatively influenced body 
weight and weight gain, and adding YCW or live yeast culture mitigated this impact. 
Performance of broilers fed diet supplemented with live yeast was as good as the 
performance of control group that fed on a corn/soybean meal based diet, especially 
during the starter phase.  
Mycotoxins are secondary metabolites of several fungi genera and adversely 
affect human and animal health and performance. These mycotoxins can be found in 
several agricultural crops such corn, soybean, and peanut. YCW adsorbs mycotoxins and 
thus diminishes their impacts. Adsorption capabilities vary depending on the dose of 
YCW and the type and concentration of mycotoxin (Zekovic et al., 2005).  
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It can be concluded from these studies that supplementing diet with YCW and/or 
yeast extract has positive effects on birds’ performance, immune response, and intestinal 
integrity. These influences are more perceptible when birds are under stress such as 
environmental, nutritional, or pathogenic challenges.     
Glucans  
 Glucans are polysaccharides that exist as natural components in plants, cereals, 
bacteria, algae, fungi, and yeast. The source of beta glucans influences their structures by 
determining how their β-D-glucose molecules are linked by glycosidic bonds (Jacob and 
Pescatore, 2014). Most beta glucans of cereal grains such as barley are unbranched with 
1, 4-β bonds, while bacterial beta glucans are unbranched with 1, 3-β-links. The glucans 
of YCW are composed of long chain β 1, 3-glucan and short chain β 1, 6-glucan. The β 
1,3-glucan chains have hollow helix structures consisting of approximately 1500 glucose 
monomers in partially hydrolyzed glucan chains that may vary depending on the 
extracted acid, growth stage and carbon source (Klis et al., 2002a). These helix 
structures make YCW elastic. In addition , β 1,6-glucose residues contribute about 3-4% 
of the mature moderate branched form of β 1,3-glucan (Manners et al., 1973). The 
literature has reported different percentages of these glucan parts in the mass of YCW. β 
1, 3-glucan comprises about 40-55% and β 1, 6-glucan comprises 5-10% of the dry 
weight of the wall, and these percentages vary with the different growth conditions of 
the yeast (Klis et al., 2002b; Lipke and Ovalle, 1998).  
 The biological responses to beta glucan depend on several factors including 
extraction procedure, solubility, molecular weight, branching, and source of the glucans. 
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Several studies have investigated biological influence of glucans on the host. However, 
most of those studies have not used pure glucan; other polysaccharides have been 
associated with their glucan. This has been especially true for livestock animal trials. 
However, in vitro or human model trials have been more advanced in this aspect. β 1,3-
glucan is in the biological response modifiers drug class because it can stimulate the 
host’s immune system and thus modifies the biological response of the host (Zekovic et 
al., 2005). Although macrophages are the part of the immune system that is most 
influenced by β 1,3-glucan, other pathways are also activated such as natural killer cells 
(NK), T-cells, the reticuloendothelial system, and antibodies titration; thus, β 1,3-glucan 
is classified as a non-specific immunomodulator (Zekovic et al., 2005).  
 The immuno-stimulatory mechanism of β 1,3-glucan in patients infected with the 
severe fungal disease paracoccidioidomycosis was investigated to evaluate the influence 
of beta glucan when those patients are treated with antifungal medicine that has an 
immunosuppression effect (Meira et al., 1996). Glucan significantly increased tumor 
necrosis factor (TNF); cytokines released from macrophages acted as an immunologic 
mediator that protected the host by stimulating the macrophages via Toll-Like Receptors 
2 (TLR2) mediation. In addition to TNF, the glucan activates macrophages by increasing 
their size and number, stimulating lysozyme secretion, and increasing antigen 
phagocytosis (Zekovic et al., 2005).  Moreover, activation response has been observed 
by beta glucan in other immune cells such as monocytes, neutrophils, eosinophils, and 
non-immune cells such as fibroblasts, alveolar epithelial cells, and endothelial cells 
(Brown and Gordon, 2003).  
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 Beside the immune activity, glucan has antitumor activity that has been 
investigated and reported to have a similar mechanism of action. One study indicated 
that β 1,3-glucan has both proliferated influence on normal bone marrow and spleen 
cells and direct cytostatic influence on tumor cells when the latter was co-incubated with 
glucan in vitro (Williams et al., 1985). Another study demonstrated that soluble (40% 
soluble glucan and 60% glucose) or particulate β 1,3-glucan of Saccharomyces 
cerevisiae can inhibit growth significantly in melanoma B16 and syngeneic anaplastic 
carcinoma as well as improve the longevity and decrease mortality rate of mice with 
subcutaneous tumor implants (Di Luzio et al., 1979). There are two receptors that 
determine the biological response to beta glucan. One of the receptors is inactivated 
complement component 3 (iC3b), also known as CR3, which is mainly present on 
neutrophils, monocytes, NK cells, and to lesser extent on macrophages. The second 
receptor is Dectin-1, which is more expressed on macrophages than neutrophils, and is 
not expressed on NK cells (Chan et al., 2009). The pharmacodynamics of fluorescein-
labeled soluble barley and particulate yeast β 1,3-glucan was investigated by an in vivo 
study in mice to explain its antitumor activity (Hong et al., 2004). The orally 
administered glucan was taken up and transported by gastrointestinal macrophages to 
bone marrow (primary lymphoid organ) and secondary lymphoid organs (spleen and 
lymph nodes). Then, the macrophages in the bone marrow broke down the large beta 
glucan particles into smaller soluble fragments, and the latter bound to the CR3 receptors 
of the granulocytes to be shuttled to the site of inflammation where they killed tumor 
cells that were iC3b-coated.  
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The phagocytes such as macrophages, neutrophils (heterophils in avian species), 
and dendritic cells express special receptors are known as pattern recognition receptors 
(PRRs) that are able to recognize simple molecules and regular patterns of molecular  
structure defined as pathogen- or microbe-associated molecular patterns (PAMPs or 
MAMPs) (Murphy et al., 2008). The immunomodulatory activities of β 1,3-glucan 
explained the antimicrobial characteristic that is proposed with fungi- and yeast-origin 
beta glucans due to their function as MAMPs (Jacob and Pescatore, 2014). The 
phagocytic and bactericidal functions against Salmonella enteritidis, as well as the 
oxidative burst of heterophils isolated from chicks, were improved significantly when 
the chicks were fed a diet supplemented with purified beta glucan (Lowry et al., 2005). 
Another study was conducted to evaluate the modulating influence of yeast beta glucans 
on performance and immune response of broilers (Zhang et al., 2008). Five levels (25, 
50, 75, 100, and 125 ppm) of 91.5% β 1,3 / 1,6-glucans were fed to male broilers and 
body weight, feed intake, and blood samples were taken on days 21 and 42. The results 
demonstrated a quadratic effect of glucan level on performance and immunological 
parameters. Feeding 50 or 75 mg/kg of glucans significantly increased body weight and 
decreased feed-to-weight gain ratio on days 21 and 42. Interleukin-1 and 2, interferon γ, 
and TNF-α were significantly higher in 50 mg/kg glucans level than control. Serum IgG, 
plasma globulin, and intestinal secretory IgA were significantly higher at 50 and 75 
mg/kg glucans. These finding suggested that 50 mg/kg of diet maximize both 
performance and humoral immune responses in broilers. Fungal beta glucans have 
similar structure to yeast beta glucans with the β 1, 3-glucan backbone with β 1, 6-
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glucan branches. Lentinan is purified from the mushroom Lentinus edodes (Shiitake) and 
is known to have antitumor properties and immunomodulatory activity on cell mediated 
and humoral immunity (Ina et al., 2013). Lentinan with > 80% purification was used in 
an  in vitro study as a typical beta glucans source at 40, 80, and 160 µg/mL to examine 
its influence on broiler splenocyte proliferation, production of IL-2, and receptor signal 
transduction of splenocytes (Chen et al., 2003). The results of this study reported a 
significant increase in splenocyte proliferation and IL-2 liberation at any level other than 
the control. In addition, calcium ion and nitric oxide both had dose-dependent increased 
response. Only 80 and 160 µg/mL increased cAMP and cGMP after 20 and 60 min 
incubation. The authors indicated that the increase in IL-2 level, because of the Ca2+ 
concentrate elevation, could partially explain the increase in splenocyte proliferation. 
Yeast beta glucans supplement (Immustim, Immudyne, Houston, TX) was used in a 
broiler study either for 7 days or 25 days at 22 ppm of the diet, and both treatments were 
subdivided into 2 groups, one of them subjected to E. coli challenge via air-sac 
inoculation on day 7 (Huff et al., 2006). Both dietary supplementation programs affected 
body weight on day 25; however, in challenged groups, feeding the broilers glucans for 
7 days prior to challenge improved body weight significantly. Although treatment effect 
was observed in feed-to-gain ratio in non-challenged groups, it was significantly 
improved when glucans were fed for 7 days and followed by pathogenic challenge than 
for the challenged control group. Intestinal integrity is very essential to obtain maximum 
feed utilization and is assessed based on villi height, the ratio of villi height to crypt 
depth, and goblet cell number. In addition, the colonization of pathogens in the 
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gastrointestinal tract impairs the histological structure and as a result impacts the 
digestibility and absorption of nutrients from the diet. In addition, pathogens increase the 
host’s immune stress and thus influence the host’s performance. Dietary β 1,3 / 1,6-
glucan extracted from Saccharomyces cerevisiae and purified at 91.5% glucan was used 
at 100 ppm in a broiler diet to investigate its influence on intestinal integrity, Salmonella 
Typhimurium colonization in the liver and ceca, and sIgA in the jejunum (Shao et al., 
2013). Challenging birds with Salmonella negatively impacted villi height, villus height 
to crypt depth ratio, and goblet cell count, and it increased colonization of this pathogen 
in the ceca. In addition, sIgA expression cells and sIgA secretion were significantly 
increased during pathogenic challenge while the tight junction proteins claudins and 
occludin, that regulate the function of the intestinal epithelial barrier, were significantly 
decreased. A diet that incorporates beta glucans significantly mitigated these adverse 
effects and diminished the damage of intestinal mucosal barrier by increasing claudins 
and occludin expression, number of goblet cells, and total sIgA production in the 
jejunum. In another study, yeast glucan (Aureobasidium pullulan) was injected into 
Peking ducks as a vaccine adjuvant with bovine serum albumin (BSA) to evaluate the 
immunological response as humoral or cell-mediated immunity (Tang et al., 2011). 
Although no influence of beta glucan was observed at the anti-BSA-IgG level, 
proliferation of blood mononuclear cells was significantly improved. These studies have 
demonstrated that beta glucans can have antitumor and immunomodulatory activities 
with bactericidal capability. Variation in these properties can be explained as the result 
of differences in source, molecular weight, polymer length, and degree of branching.   
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Mannoproteins           
Another major component of YCW is mannoproteins which are O and N 
glycosylated polypeptides found on the outer surface of the YCW; they regulate 
permeability of the wall to solutes (Lipke and Ovalle, 1998). Mannoprotein complexes 
represent 40% of the yeast wall mass with mean molecular weight between 100-200 
kDa, and have  N-glycans consisting of α-linked mannose units with a long 1,6-α-linked 
backbone and short 1,2- and 1,3-α-linked side chains (Orlean, 1997). The mannoproteins 
complex can be obtained from YCW by hot citrate buffer extraction, sulfhydryl reagent 
liberation, and P-glucanases digestion (Orlean, 1997).  
Mannose acts as a key in lock-and-key interactions with lectins, carbohydrate-
binding proteins, which act as a lock, that are found on the surface of bacteria and thus 
inhibits enterobacteria that exhibit Type-1 fimbriae adhesiveness to the surface of host 
cells (Zopf and Roth, 1996). The anti-adhesive property of mannose reduces bacterial 
colonization and may increase microbial susceptibility to antibiotics (Zopf and Roth, 
1996). The adhesion strength between mannose and binding proteins can be increased 
when the sugar molecules are linked to a polymer backbone to form polyvalent 
oligosaccharides, which are stronger antiadhesive macromolecules (Lees et al., 1994). 
However, this polyvalent complex is not recognized as a host molecule and could be 
toxic or immunogenic to the host (Zopf and Roth, 1996). Several strains of E. coli, 
Salmonella typhimurium, and S. enteritidis have been reported as able to agglutinate 
MOS in vitro (Spring et al., 2000).  
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The application of YCW extracted from Saccharomyces cerevisiae as a source of 
mannan-oligosaccharides in animal trials has been heavily investigated to assess their 
potential as alternatives to antibiotic growth promoters (Bozkurt et al., 2012; Che et al., 
2011; Ghasemian and Jahanian, 2016; Jahanian and Ashnagar, 2015; Sohail et al., 2012; 
Spring et al., 2000; Tian et al., 2016; Xiao et al., 2012). However, YCW has other major 
components beside MOS such as glucans and protein that make it inaccurate to describe 
YCW products as MOS. Nevertheless, literature has linked several beneficial effects to 
the supplementation of MOS in the feed of different animal species in addition to the 
anti–adhesion characteristic. One of these benefits is the immunomodulatory effect of 
MOS that increases cecal IgA in rats, bile IgA and systemic IgG in turkeys, and 
neutrophils in dog and fish (Swanson et al., 2002). However, this study did not provide 
the purity of the MOS that was used and the same product was defined in another study 
as a product contains YCW fragments derived from Saccharomyces cerevisiae (Spring et 
al., 2000). 
The availability of pure MOS at feasible cost to conduct in vivo studies has been 
a challenge. Therefore, studies have been using different sources of less purified MOS 
that may contain other components. In poultry, it was reported that supplementation of 
feed with YCW as a source of MOS improved animal performance and health. Spring et 
al. (2000) reported that adding YCW at 4000 ppm (YCW was added at this level to 
ensure sufficient concentration of MOS to control colonization of pathogens) as a source 
of MOS reduced Salmonella population in the ceca of 10-day-old broiler chicks.   
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Clostridium perfringens         
Clostridium perfringens (Cp) is an anaerobic gram-positive spore forming rod-
shaped bacteria ubiquitous in the environment and part of the normal gastrointestinal 
microbiota (Timbermont et al., 2009). The Cp pathogen produces about 17 toxins, and 
based on the subset of four important toxins (α, β, ε, and ι) that are produced by 
individual strains, Cp is classified into five toxinotyping classifications; A, B, C, D, and 
E (Freedman et al., 2015). Cp employees its exotoxins to obtain thirteen essential amino 
acids because it does not have genetic mechanism to produce them (Cooper and Songer, 
2009). This bacterium is one of the most common foodborne illness causing pathogens 
in the United States and is estimated to cause approximately 1 million cases/year of 
foodborne illness (CDC, 2015). The estimated cost of foodborne illness due to Cp is 
about $342 million in the United States (ERS, 2013). In poultry, it is estimated that the 
global cost associated with necrotic enteritis (NE) due to Cp is approximately $2 billion 
(McReynolds et al., 2004).  
Clostridium perfringens causes clinical and/or subclinical classes of NE in 
poultry. The clinical type is classified into acute and peracute forms that are both 
characterized by diarrhea, ruffled feathers, anorexia, depression, and occasional sudden 
death with no clinical signs; however, the peracute form mostly causes mortality of up to 
50% of the flock within hours of the appearance of symptoms (Freedman et al., 2015). 
The subclinical form of necrotic enteritis is characterized by low mortality, declined 
production, little or no diarrhea, and decreased weight gain and feed efficiency due to 
the chronic damages to the gut mucosa that cause mal-digestion and mal-absorption 
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(Freedman et al., 2015; Van Immerseel et al., 2009). Type A of Cp is the most common 
cause of NE, and type C is less common (Cooper and Songer, 2009). There are several 
factors that can establish and intensify the Cp infection and exacerbate its impact on the 
birds, such as feed ingredients, feed form, protein and energy contents, animal protein 
level, secondary parasitic infection, and low intestinal pH (Cooper and Songer, 2009).  
For decades, it was understood that α toxin produced by Cp type A was the main 
toxin that causes NE in chickens, due to the work of (Al-Sheikhly and Truscott, 1977). 
This study infused supernatant of crude alpha and theta toxins extracted from the broth 
cultures of Cp type A into the duodenum of 4-week-old male broilers. However, there 
was no clear explanation of the assumption that α toxin was the causative agent of NE, 
although it was part of crude supernatant toxins (Van Immerseel et al., 2009). Keyburn 
et al. (2006) reported that α toxin mutant is virulent just like the toxin itself, and thus the 
latter is an unnecessary factor in NE infection, especially as not all α toxin producing 
strains of Cp cause NE. Recent study has proposed a novel toxin called Necrotic 
Enteritis Toxin B-like (NetB), which is produced by Cp type A strains isolated from NE-
positive chickens and is the most virulent toxin associated with NE in poultry (Keyburn 
et al., 2008). This toxin shares some similarities with amino acid sequences of β toxin 
from Cp at 38% identity and α toxin from Staphylococcus aureus at 31% identity. 
Another factor that was proposed to cause NE is the collagenolytic activity of matrix 
metalloproteinases (MMPs), proteolytic enzymes which have a destructive effect on the 
lamina propria, the extra-cellular matrix, and intercellular junctions which lead to 
enterocytes’ necrotic death (Olkowski et al., 2008).  
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Chicken-specific peptides arrays 
 In eukaryotic cells, most of the signal transduction and other cellular processes 
such as transcription, cytoskeletal rearrangement, apoptosis, immune system 
functioning, and metabolism are controlled by protein kinases (Manning et al., 2002). 
Studying active kinase enzymes is crucial to understanding cellular function since they 
can demonstrate their influences on their corresponding substrates (Arsenault and Kogut, 
2012). With more than 1000 predicted protein kinases in the vertebrate genome (Hunter, 
1987), only 518 human protein kinases were identified, which constitute approximately 
1.7% of human genes (Manning et al., 2002). Peptide arrays, antibody based array, and 
spectrophotometry techniques are among several other methodologies that are used for 
kinomics studies; however, peptide arrays have widely available reagents and 
exclusively deal with active kinase (Arsenault and Kogut, 2012). In kinomics, the 
principles of peptide arrays start with: 1) the employment of kinase target sites, usually 
15 amino acids, peptides, made and printed onto array surface, 2) applying a sample of a 
mixture of purified kinase or cellular lysate as a source of active protein kinases on the 
array, 3) the active kinases identify their kinase target sites and phosphorylate the serine, 
threonine, or tyrosine residue on the target peptides sequence by using γ-phosphate 
group-added ATP, and 4) visualization the phosphorylation process (Arsenault and 
Kogut, 2012).  
 Peptide arrays have been employed to understand cellular signaling in different 
conditions such as describing reactions to specific singular ligands, describing changes 
in phosphorylation-mediated signal transduction in disease condition, or studying cancer 
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(Arsenault et al., 2011). Until a short time ago, the wealth of online public 
phosphorylation databases are particularly for humans and mice. Recently, species-
specific peptide arrays have been developed to study the kinomics of other species such 
as bovine, ovine, and chicken (Arsenault and Kogut, 2012; Jalal et al., 2009). Chicken-
specific peptide arrays have been used to study the skeletal muscle metabolic change 
over time after Salmonella Typhimurium challenge (Arsenault et al., 2013). This study 
reported significant changes in AMPK phosphorylation and the insulin/mammalian 
target of the rapamycin (mTOR) signaling pathway. Chicken-specific peptides have the 
advantages of eliminating the possibility of cross-reactivity between chicken kinases and 
human or mouse phosphorylation target sites, maximizing the interaction potential, and 
preventing failed interaction between peptide epitopes of other species and chicken 
proteins (Arsenault and Kogut, 2012).  
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CHAPTER II 
INFLUENCE OF DIFFERENT YCW PREPARATIONS AND YCW 
COMPONENTS ON BROILER PERFORMANCE AND METABOLIC 
PATHWAYS 
 
Introduction 
Antimicrobials are employed at sub-therapeutic levels to suppress the growth of 
pathogenic bacteria and improve performance of farm food animals. However, the 
increased demand to limit or ban the use of antibiotics at sub-therapeutic levels in 
livestock feed accelerates the urge to explore versatile antibiotic alternatives. Those 
alternatives have demonstrated variabilities and inconstant results in their influences on 
animal health and performance. These fluctuated effects are being observed not only 
with different types but also within the same antibiotic alternative.  
Yeast cell wall (YCW) of Saccharomyces cerevisiae is one of those alternatives 
that has been investigated in vivo and in vitro and used commercially in animal feed. 
Mannan oligosaccharide (MOS) and beta glucans are the main two components of YCW 
that have been thought to contribute to its beneficial effects on host health and 
performance (Shao et al., 2013; Spring et al., 2000). Studies have demonstrated a 
quadratic response to YCW in starter broiler (Fowler et al., 2015b) and laying hen 
performance (Hashim et al., 2013), and the 250 ppm level is proposed to be an optimum 
dose.  
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The structure of YCW consists of the polysaccharides glucan and mannan, which 
links to proteins to form mannoproteins, lipids and chitin. However, the percentage of 
each component varies due to differences in fermentation conditions and cultivation 
methods. In addition, more than 600 strains of Saccharomyces cerevisiae have been 
identified and categorized into three main groups according to their substrates as wine, 
beer, and bread (Legras et al., 2007). This variation could be one of the factors 
contributing to the different outcomes that have been reported in the literature.  
Challenges of foodborne pathogens in food production animals have intensified 
with increased switching over to antibiotic-free products. Clostridium perfringens is one 
of those pathogens that causes about one million cases per year of foodborne illness in 
the United States as reported by the Centers for Disease Control and Prevention (2016). 
The Economic Research Unit of the USDA estimated the annual medical and premature 
death cost of foodborne disease due to Clostridium perfringens at more than $342 
million dollars in 2013 (ERS, 2013). 
In addition to human health hazard, this pathogen causes significant damages and 
cost to the food production animal industry. The economic cost associated with this 
pathogen in livestock animals is due to its negative impact on animal health and 
performance because of the secretion of its toxins that can cause necrotic enteritis at 
different clinical levels. Increased mortality, morbidity, and gut lesions are the main 
signs associated with clinical necrotic enteritis. The subclinical form of necrotic enteritis, 
on the other hand, is characterized by performance retardation due to male digestion and 
absorption (Yitbarek et al., 2012). Although these signs and characteristics of necrotic 
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enteritis are noticeable, there are other mechanisms in the background that can explain 
the long-term changes in the host. 
Understanding these mechanisms can improve and accelerate strategies to 
develop or invent new antimicrobial alternatives to counter this pathogen. Kinomic 
studies have the potential to provide understanding of cellular biology and response to 
stimuli such as disease, condition, or treatment via consideration of phosphorylation-
mediated signal transduction (Arsenault and Kogut, 2012). The peptide arrays technique 
examines the active kinases, which, in addition to the availability of the reagents, makes 
it better than other kinomics procedures such as mass spectrometry and antibody based 
arrays (Arsenault and Kogut, 2012). Cellular metabolic signaling using chicken species-
specific peptide arrays was first introduced by Arsenault et al. (2013) to study the 
changes in skeletal muscle metabolism over time after Salmonella Typhimurium 
infection. Their study suggested that metabolism of skeletal muscle is influenced by 
systemic effects of this pathogen via AMPK phosphorylation, which can signal ATP 
production, and activity alterations as well as insulin/mTOR signaling pathway 
disruptions, which can alter glucose metabolism.  
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The purpose of our study was to evaluate the influence of different products of 
YCW on starter broiler performance. These products have different purification levels as 
well as different preparation techniques. The evaluation was conducted through 
monitoring applicable production performance attributes such body weight and feed 
conversion ratio. In addition, to help understand the mechanism of these changes in 
performance characteristics, a chicken species-specific peptide arrays technique was 
employed in this study.  
 
Materials and Methods 
Experimental design  
 This study was conducted to evaluate purified and semi-purified YCW 
preparations on starter broiler performance. A total of 240 Ross 308 (1-day-old) chicks 
were distributed between two battery brooder units (48 pens; 5 birds/pen). Six treatments 
were randomly assigned to pens and each treatment had eight replicates. A basal broiler 
starter diet (Table 2.1) was prepared and divided into five batches that included non-
challenge (T1) and challenge (T2) control (NCh-Cont and Ch-Cont respectively), semi-
purified YCW (250 ppm; SPYCW or T3), purified YCW (250 ppm; PYCW or T4), 50% 
purified beta-glucan YCW (130 ppm; BG or T5), and 99.9% purified MOS (53 ppm; 
MOS or T6). The YCW components were 23.5% MOS and 23% β-glucans. The 
SPYCW, PYCW, and BG preparations were provided by (Phileo-Lesaffre Animal Care, 
Milwaukee, WI) and MOS (≥ 99.7% purified from baker’s Saccharomyces cerevisiae) 
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purchased from Sigma (Sigma-Aldrich, St. Louis, MO). Mortality within the first three 
days was replaced with new birds that had been fed on the control diet.  
All birds of six treatments were challenged with infectious bursal disease vaccine 
(Schering Plough Animal Health, Millsboro, DE) on day 10. The vaccine was 
administered at 10x the manufacturer’s recommended dose via the ocular route to 
immunocompromised the chicks (McReynolds et al., 2004). On day 16 and 17, all 
treatments were challenged with Clostridium perfringens (Cp) (107 cfu/mL, 3 mL oral 
gavage). Feed and water were provided ad libitum. Feed and body weight data were 
recorded on days 1, 10, 16 and 21. Performance index (PI) was calculated as: livability 
(%) x BW (kg)/Age (d)/FCRx100. The study was conducted at the Southern Plains 
Agricultural Research Center, Agricultural Research Service, United States Department 
of Agriculture and was approved by the Texas A&M Institutional Animal Care and Use 
Committee and the Animal Care and Use Committee (ACUC) at the Southern Plains 
Agricultural Research Center. 
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Table 2.1 Composition and nutrient content of the basal starter diet for the yeast 
cell wall purification study. 
Ingredient Amount 
Corn (%) 61.40 
Dehulled soybean meal (%) 32.18 
DL-Methionine 98% (%) 0.23 
Lysine HCl (%) 0.18 
Fat, blended animal/vegetable (%) 2.22 
Limestone (%) 1.44 
Mono-dicalcium phosphate (%)  1.55 
Salt (%) 0.51 
Trace minerals premix1 (%) 0.05 
Vitamin premix2 (%) 0.25 
Calculated nutrient content 
CP (%) 22.12 
ME (Kcal/kg) 3050 
Crude fat (%) 4.06 
Crude fiber (%) 2.15 
Calcium (%) 0.95 
Available phosphate (%) 0.45 
Sodium (%) 0.22 
Methionine (%) 0.56 
Lysine (%) 1.31 
1Trace minerals premix added at this rate yields (mg/kg): zinc, 60.0; manganese, 60.0. 
2Vitamin premix added at this rate yields (per kg): vitamin A, 11 kIU; vitamin D3, 3,850 IU; vitamin E, 
45.8 IU; menadione, 1.5 mg; B12, 0.017 mg; biotin, 0.55 mg; thiamine, 2.93 mg; riboflavin, 5.96 mg; d-
pantothenic acid, 20.17 mg; B6, 7.15 mg; niacin, 45.8 mg; folic acid, 1.74 mg; choline, 130.3 mg.  
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Isolation and administration of Clostridium perfringens 
 Clostridium perfringens (Cp) medium was provided by the ARS, Southern Plains 
Agricultural Research Center/USDA. The isolation and preparation of Cp were as 
described in McReynolds et al. (2004). The Cp pathogen was a combination of four field 
isolates type A from three different regions (Georgia, Texas, and Virginia). These 
isolates were cultured individually, combined, and administered to the birds. Then, about 
one gram of the GI contents of birds diagnosed with necrotic enteritis was taken in an 
anaerobic chamber and placed onto 10 mL of liquid thioglycollate medium (Becton 
Dickinson Co., Sparks, MD) and incubated for 24 h at 37ºC.  
The bacteria were streaked on to Brucella blood agar plates (Anaerobic Systems, 
Morgan Hill, CA) using a 10-µL loop, and those plates were incubated for 24 h at 37ºC. 
To ensure purity, a single colony was removed from the plate and streaked onto Brucella 
blood agar. Bacteria were frozen with 20% glycerol at -80ºC, and when pathogenic 
challenge was needed, the bacteria were grown in a thioglycollate medium for 12 h prior 
to challenge. All treatments except non-challenged birds were challenged with 3 mL of 
Cp (107 cfu/mL) through oral gavage on days 16 and 17. 
Intestinal tissue sampling  
 Tissue samples from the duodenum and jejunum of five birds per treatment were 
collected and sent to the Southern Plains Agriculture Research Center / USDA 
laboratory to conduct kinome analysis using the chicken-specific peptide arrays 
technique as described by Arsenault et al. (2013). Three birds of each treatment were 
euthanized with CO2 and dissected to collect the samples. These samples were 
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immediately flash frozen with liquid nitrogen to maintain kinase enzymatic activity and 
shipped to the USDA lab. 
Chicken-specific peptide arrays 
 This technique was conducted according to the methodology that was described 
by Arsenault et al. (2013). Briefly, 40 mg samples were obtained from the tissues 
collected above and homogenized by a hand-held Qiagen TissueRuptor (Valencia, CA, 
USA) in 100 uL of lysis buffer (20 mM Tris–HCl pH 7.5, 150 mM NaCl,1 mM EDTA, 1 
mM Ethylene glycol tetraacetic acid (EGTA), 1% Triton X-100, 2.5 mM sodium 
pyrophosphate, 1 mM Na3VO4, 1 mM NaF, 1 μg/mL leupeptin, 1 g/mL aprotinin and 1 
mM phenylmethylsulphonyl fluoride (Sigma Aldrich, St. Louis, MO, USA). The 
following steps of the protocol were carried out as described by Arsenault et al. (2012): 
Cells were incubated on ice for 10 min and spun in a microcentrifuge for 10 min at 4°C. 
A 70-μL aliquot of this supernatant was mixed with 10 μL of activation mix (50% 
glycerol, 500 μM ATP [New England BioLabs, Pickering, ON, Canada], 60 mM MgCl2, 
0.05% [vol/vol] Brij 35, and 0.25 mg/mL bovine serum albumin [BSA]) and incubated 
on the array for 2 h at 37°C. Arrays were then washed with phosphate-buffered saline 
(PBS)–1% Triton. 
Slides were submerged in phospho-specific fluorescent ProQ Diamond 
Phosphoprotein Stain (Invitrogen) with agitation for 1 h. Arrays were then washed three 
times in destaining solution containing 20% acetonitrile (EMD Biosciences, VWR 
Distributor, Mississauga, ON, Canada) and 50 mM sodium acetate (Sigma) at pH 4.0 for 
10 min. A final wash was done with distilled deionized H2O. Arrays were air dried for 
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20 min and then centrifuged at 300 × g for 2 min to ensure no moisture was remaining 
on the array.  
Arrays were read using a GenePix Professional 4200A microarray scanner (MDS 
Analytical Technologies, Toronto, ON, Canada) at 532 to 560 nm with a 580-nm filter to 
detect dye fluorescence. Images were collected using GenePix version 6.0, software 
(MDS), and the spot intensity signal was collected as the mean of pixel intensity using 
local feature background intensity calculation with the default scanner saturation level. 
Statistical analysis  
 Body weight, weight gain, and feed conversion ratio data were analyzed as a one-
way ANOVA using the General Linear Model of SPSS software. Pen level was used as a 
block to control variation among groups of experimental units, and the design of the 
experiment was an incomplete block. Means deemed significant at p ≤ 0.05 were 
separated using a protected Duncan’s Multiple Range Test. 
 Peptide arrays data, images were gridded using GenePix pro software, and the 
spot intensity signal was collected as the mean of pixel intensity using local feature 
background intensity calculation with default scanner saturation level. The resultant data 
was then analyzed by the PIKKA2 peptide array analysis software. Briefly, the resulting 
data points were normalized to eliminate variance due to technical variation such as 
random variation in staining intensity between arrays or between array blocks within an 
array. Variance stabilization normalization was performed. (3 values/peptide). One-sided 
paired t-test between treatment and control values for a given peptide was conducted to 
calculate the p-value.  
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Results and Discussion  
This experiment was conducted to assess the influence of different YCW 
preparations containing different concentrations of β-glucans or mannan 
oligosaccharides on starter broiler performance in the presence of microbial stress. 
Performance data were calculated and analyzed on days 10 (pre-vaccination), 16 (pre-
challenge) and 21 (post-challenge). In addition, a chicken-specific peptide arrays 
technique was employed to study the mechanism of these YCW products in ameliorating 
the impact of Cp using samples collected on day.  
Broiler performance  
 The 99% purified MOS treatment demonstrated a significant increase in body 
weight (BW) and weight gain (WG) on day 10 (Table 2.2), pre-vaccination, with an 
approximately 24-41 g difference from all other groups. No significant differences were 
observed between treatments in phase 1 feed-to-gain ratio (P-F:G), feed-to-body weight 
ratio (FCR), or phase mortality (P-Mort). There was no mortality observed in this phase 
in all treatments, except the MOS group had 5% mortality.   
 On day 16, pre-challenge and after birds been immunocompromised with a high 
dose of bursa vaccine, the 99% MOS treatment had significantly higher BW (559 g) than 
the semi-purified and 50% glucan treatments (490 and 513 g, respectively). The semi-
purified YCW treatment exhibited significantly lower WG (246 g) than all other 
treatments except the 50% glucan treatment (263 g), and the latter was as good as the 
MOS group (274 g), but lower than the purified YCW, Ch-Cont, and NCh-Cont 
treatments (290, 291, and 301 respectively). The feed utilization was not efficient in 
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semi-purified treatment as well as 50% glucan and MOS treatments compared to other 
treatments. These three treatments had higher Phase 2 P-F:G (1.50, 1.50, and 1.54 
respectively) and cumulative feed to gain ratio (C-F:G) (1.38, 1.39, and 1.38 
consecutively) than purified YCW, Ch-Cont, and NCh-Cont treatments (1.31 for all last 
three treatments). The FCR scenario was not different from Phase 2 P-F:G or C-F:G 
except that semi-purified YCW treatment was not significantly different from Ch-Cont, 
NCh-Cont, or purified YCW treatments. The performance index (PI), which is based on 
BW, P-F:G, and mortality, was significantly lower in semi-purified YCW (222) and 50% 
glucan (232) groups than Ch-Cont (261), NCh-Cont (268) and purified YCW (261) 
treatments. The MOS treatment was not significantly different in PI (242) from Ch-Cont 
or Purified YCW, but was less than NCh-Cont.  No mortality was recorded in phase 2 
for all treatments (Table 2.3).  
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Table 2.2 Effect of yeast cell wall purification on broiler performance on day 10 (pre-immunocompromised). 
 
Treatment group1 
NCh-Cont2 Ch-Cont2 SPYCW PYCW BG MOS 
BW (g) 261 ± 19b 258 ± 34b b244 ± 14 258 ± 27b 250 ± 19b 285 ± 20a 
WG (g) 217 ± 17b 214 ± 34b 201 ± 14b 215 ± 27b 206 ± 20b 241 ± 19a 
P-F:G 1.22 ± 0.04 1.21 ± 0.04 1.24 ± 0.05 1.19 ± 0.05 1.24 ± 0.06 1.20 ± 0.04 
FCR 1.02 ± 0.03 1.00 ± 0.04 1.02 ± 0.05 0.99 ± 0.04 1.03 ± 0.05 1.01 ± 0.03 
PI 214 ± 22 214 ± 22 197 ± 11 217 ± 24 201 ± 19 226 ± 29 
P-Mort 0.0 0.0 0.0 0.0 0.00 5% 
a-b Means ± SD within a row lacking a common superscript differ (P ≤ 0.05).  
1NCh-Cont = non-challenged control; Ch-Cont = challenged control; SPYCW = semi-purified yeast cell wall (YCW) at 250 pm; PYCW = purified 
YCW at 250 ppm; BG = 50% purified β-glucan at 130 ppm; MOS = 99.9% purified mannan-oligosaccharides at 53 ppm.  
2NCh-Cont and Ch-Cont birds fed control diet, but differ on day 16 and 17 when Ch-Cont birds were challenged with Clostridium perfringens. 
BW = body weight; WG = weight gain; P-F:G = phase feed:gain; FCR = feed conversion ratio; PI = performance index; P-Mort = phase mortality.  
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Table 2.3 Effect of yeast cell wall purification on broiler performance on day 16 (pre-challenge). 
 
Treatment group1 
NCh-Cont2 Ch-Cont2 SPYCW PYCW BG MOS 
BW (g) 561 ± 29a 549 ± 52ab c490 ± 21 549 ± 37ab 513 ± 32bc 559 ± 43a 
WG (g) 301 ± 11a 291 ± 24ab 246 ± 18d 290 ± 16ab 263 ± 16cd 274 ± 29cb 
P-F:G 1.38 ± 0.04a 1.40 ± 0.11a 1.50 ± 0.10b 1.41 ± 0.06a 1.50 ± 0.04b 1.54 ± 0.11b 
C-F:G 1.31 ± 0.03a 1.31 ± 0.06a 1.38 ± 0.07b 1.31 ± 0.04a 1.39 ± 0.04b 1.38 ± 0.07b 
FCR 1.21± 0.03a 1.21 ± 0.06a 1.26 ± 0.06ab 1.21 ± 0.04a 1.27 ± 0.04b 1.27 ± 0.06b 
PI  268 ± 18a 261 ± 26ab 222 ± 16c 261 ± 19ab 232 ± 16c 242 ± 34bc 
P-Mort 0.0 0.0 0.0 0.0 0.00 0.0 
C-Mort  0.0 0.0 0.0 0.0 0.0 5% 
a-d Means ± SD within a row lacking a common superscript differ (P ≤ 0.05).  
1NCh-Cont = non-challenged control; Ch-Cont = challenged control; SPYCW = semi-purified yeast cell wall (YCW) at 250 pm; PYCW = purified 
YCW at 250 ppm; BG = 50% purified β-glucan at 130 ppm; MOS = 99.9% purified mannan-oligosaccharides at 53 ppm.  
2NCh-Cont and Ch-Cont birds fed control diet, but differ on day 16 and 17 when Ch-Cont birds were challenged with Clostridium perfringens. 
P-F:G = phase feed:gain; C-F:G = cumulative feed:gain; PI = performance index; P-Mort = phase mortality; C-Mort = Cumulative mortality.  
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On day 21 (Table 2.4), post Cp challenge, birds in the NCh-Cont group 
demonstrated significantly higher BW (851 g), WG (289 g), and PI (274) than birds in 
the Ch-Cont group (that experienced 755 g, 206 g, and 199, respectively). The BW of 
the birds in the purified YCW (797 g) and MOS (805) groups was not significantly 
different from BW of NCh-Cont, but was significantly higher than semi-purified birds 
(712 g). The BW of 50% glucan birds (742 g) was significantly lower than NCh-Cont 
but was not significantly different from other treatments.   
 The phase 3 WG of the birds in both purified YCW (248 g) and MOS (247 g) 
treatments was not significantly different from NCh-Cont or all other treatments. 
However, the gain in body weight after the Cp challenge was significantly lower in 
semi-purified (222 g) or 50% glucan (232 g) treatment than the NCh-Cont group. Only 
the birds in purified YCW treatment demonstrated PI (238) not significantly different 
from NCh-Cont or other treatments. The PI of semi-purified YCW (203), 50% glucan 
(203), and MOS (202) treatments were significantly lower than NCh-Cont but were not 
different from Ch-Cont. No significant differences were observed between treatments in 
P-Mort and cumulative mortality (C-Mort).  
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Table 2.4 Effect of yeast cell wall purification on broiler performance on day 21 (post-challenge). 
 
Treatment group1 
NCh-Cont2 Ch-Cont2 SPYCW PYCW BG MOS 
BW (g) 851 ± 62a 755 ± 110bc c± 38 712 797 ± 62ab 742 ± 20bc 805 ± 72ab 
WG (g) 289 ± 44a 206 ± 72b 222 ± 30b 248 ± 45ab 232 ± 35b 247 ± 41ab 
P-F:G 1.75 ± 0.34 2.28 ± 0.50 1.92 ± 0.21 1.85 ± 0.13 2.00 ± 0.42 1.99 ± 0.55 
C-F:G 1.45 ± 0.09 1.53 ± 0.07 1.55 ± 0.10 1.48 ± 0.04 1.55 ± 0.08 1.52 ± 0.12 
FCR 1.38 ± 0.03a 1.44 ± 0.06 1.55 ± 0.10 1.39 ± 0.04 1.46 ± 0.08 1.43 ± 0.11 
PI 274 ± 45a 199 ± 57b 203 ± 33b 238 ± 31ab 203 ± 32b 202 ± 77b 
P-Mort 2.5%  15.0%  7.5%  7.5%  11.4%  18.1%  
C-Mort  2.5%  15.0%  7.5%  7.5%  11.4%  22.5%  
a-c Means ± SD within a row lacking a common superscript differ (P ≤ 0.05).  
1NCh-Cont = non-challenged control; Ch-Cont = challenged control; SPYCW = semi-purified yeast cell wall (YCW) at 250 pm; PYCW = purified 
YCW at 250 ppm; BG = 50% purified β-glucan at 130 ppm; MOS = 99.9% purified mannan-oligosaccharides at 53 ppm.  
2NCh-Cont and Ch-Cont birds fed control diet, but differ on day 16 and 17 when Ch-Cont birds were challenged with Clostridium perfringens. 
P-F:G = phase feed:gain; C-F:G = cumulative feed:gain; PI = performance index; P-Mort = phase mortality; C-Mort = Cumulative mortality. 
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Peptide arrays 
 On day 21, tissue samples were collected from three birds of each treatment from 
the duodenum and jejunum to study the chicken immune and metabolic signaling 
pathways using chicken-specific peptide arrays. The immune and metabolic pathways 
response in the duodenum and jejunum areas to the Cp challenge and YCW or its 
components was different (Figures 2.1 and 2.2). The results demonstrated that Cp 
challenge resulted in changes in the phosphorylation status of 367 peptides in the 
duodenum and 459 peptides in the jejunum of infected birds. The YCW wall or its 
components influenced changes in signaling pathways. In the duodenum, the percent of 
similarity coefficient (%CV) to NCh-Contr was 59.40% for glucan, 42.78% for semi-
purified YCW, 33.97% for MOS, and 29.97% for purified YCW. In the jejunum, the 
purified YCW demonstrated higher similarity than other treatments. The CV% to NCh-
Cont was 80.61% in purified YCW, 74.07% in semi-purified YCW, 69.06% in glucan, 
and 52.94% in MOS treatment. The signaling pathways of MOS and glucan are more 
like the purified YCW than like each other. In addition, the purified YCW was able to 
generate signaling that was not identical to either d by either of the YCW components 
alone. 
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Figure 2.1 Dendrogram of peptide arrays comparing similarity in metabolic 
pathways in the duodenum and jejunum of 21 days of age broilers.  
 
Relative similarity of band patterns is indicated by their grouping on the dendrogram and the percentage 
similarity coefficient (bar). NCh-Cont = non-challenged control; Ch-Cont = challenged control; SPYCW = 
semi-purified yeast cell wall (YCW) at 250 pm; PYCW = purified YCW at 250 ppm; BG = 50% purified 
β-glucan at 130 ppm; MOS = 99.9% purified mannan-oligosaccharides at 53 ppm.  
NCh-Cont and Ch-Cont birds fed control diet, but differ on day 16 and 17 when Ch-Cont birds were 
challenged with Clostridium perfringens. 
J = Jejunum, D = Duodenum.  
MOS J 
      Ch-Cont J  
PYCW D 
Ch-Cont D 
MOS D 
SPYCW J 
PYCW J 
NCh-Cont J 
BG D  
SPYCW D 
NCh-Cont D 
BG D 
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Figure 2.2 Dendrogram of peptide arrays comparing similarity in metabolic 
pathways of mannan oligosaccharides vs challenged control in the duodenum and 
jejunum of 21 days of age broilers. 
 
Relative similarity of band patterns is indicated by their grouping on the dendrogram and the percentage 
similarity coefficient (bar). NCh-Cont = non-challenged control; Ch-Cont = challenged control; SPYCW = 
semi-purified yeast cell wall (YCW) at 250 pm; PYCW = purified YCW at 250 ppm; BG = 50% purified 
β-glucan at 130 ppm; MOS = 99.9% purified mannan-oligosaccharides at 53 ppm.  
NCh-Cont and Ch-Cont birds fed control diet, but differ on day 16 and 17 when Ch-Cont birds were 
challenged with Clostridium perfringens 
J = Jejunum, D = Duodenum.  
             MOS J 
             BG J 
      NCh-Cont J 
        SPYCW J 
         PYCW J 
             MOS D 
             BG D 
      SPYCW D 
           PYCW D 
      NCh-Cont D 
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The Cp challenge successfully impaired the starter broiler performance as 
demonstrated by BW, WG and PI reduction in control challenged birds on day 21 of age 
(after the Cp challenge). The application of YCW in broiler diets has been under heavy 
investigation with different nutritional, environmental, and pathological conditions or 
stresses. The goal of these type of studies was mainly to test the hypothesis whether 
YCW can be used as an alternative to the prophylactic use of antibiotics to promote 
growth in food production animals. The findings of this study reported that purified 
YCW, which is a typical commercial YCW product with typical MOS and glucan 
proportions, had no significant impact on broiler performance during the first 16 days of 
age under a controlled study environment. This is in agreement with the results of other 
researchers (Fowler et al., 2015b; M'Sadeq et al., 2015) who reported that the 
supplementation of YCW in broiler feed had no influence on performance in the early 
stage of age with no stressor. However, on day 21 of age and after Cp challenge, purified 
YCW was able alleviate the negative impact of Cp on broiler performance. Similar 
influence of YCW was reported in other studies when birds were subjected to Cp 
challenge (Fowler et al., 2015b; M'Sadeq et al., 2015). On the contrary, Yitbarek et al. 
(2012) reported that YCW could not improve BW in broiler starter birds challenged with 
Cp. However, their study supplemented the diet with 2000 ppm of YCW. Fowler et al. 
(2015b) stated that YCW has a quadratic effect on broiler performance and higher doses 
than 500 ppm could start to impair broiler performance.  
Baker’s YCW is a byproduct of Saccharomyces cerevisiae yeast extract 
production. Before YCW is obtained from yeast extract, the yeast itself undergoes 
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fermentation and maturation steps (ERUASYP, 2015). The fermentation occurs in large 
containers by adding sugar with sufficient oxygen supply at 30 °C. This is followed by 
concentration and washing steps in a centrifuge to remove the sugar residues and 
produce a creamy viscous yeast mass. The maturation of the later product is performed 
at 45-55 °C. When the temperature reaches 40 °C, yeast growth ceases, enzymes break 
down the yeast protein and part of the YCW disintegrates. To separate the remaining 
YCW from the yeast extract, a centrifugation step is performed. Therefore, the degree of 
purification of the final YCW product can vary. This study utilized purified and semi-
purified YCW products. The latter included a byproduct of the yeast extract production 
process.  
The performance of starter broiler birds significantly declined starting on day 16, 
after the immunocompromised challenge, and continued on day 21, post-pathogenic 
challenge. Other unpublished studies were conducted in our lab to evaluate the semi-
purified YCW and the results were in agreement with the outcomes of the current study.  
Glucan and MOS are the main polysaccharide components of YCW. Previous 
literature has used the terms MOS or glucan to describe YCW products and has referred 
to either one of them as the subject of their research. The availability of commercial pure 
MOS or glucan is cost prohibitive. Therefore, 99% purified MOS was obtained from 
Sigma to evaluate its influence on broiler performance and understand the mechanism of 
action. Glucan was provided as 50% purified from the YCW of Saccharomyces 
cerevisiae. Both of these components were included at levels equivalent to their 
proportion in YCW. The performance of the starter broiler birds was significantly 
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improved when the diet was supplemented with 99% MOS. This improvement was 
noticeable starting on day 10 in body weight. Moreover, the performance of the birds in 
the MOS treatment was not impacted by the immunocompromising high bursa vaccine 
dose. Addition of MOS to the diet increased the resistance of the birds to the impact of 
Cp on day 21, post-challenge, which was indicated by improved body weight and PI in 
MOS treatment birds to make them as good as non-challenged control birds. Addition of 
glucan purified at 50% of baker’s YCW to broiler diet did not improve the performance 
of starter broiler birds. This may indicate that additional tests of this component at 
variable levels are needed.  
In another study, glucan was extracted from Saccharomyces cerevisiae at 91% of 
the content of the extract and added to the diet of broilers infected with Salmonella 
(Shao et al., 2013). The study reported that 100 ppm of glucan improved intestinal 
integrity and immunity. The villus height, villus height:crypt depth ratio, goblet cell 
number, and sIgA expression cells and content in the jejunum were increased. In 
addition, Salmonella colonization in the ceca and invasion into the liver were inhibited. 
The study also reported that β-glucan improved the intestinal tight junction proteins in 
infected birds. Claudin-1 and occludin mRNA expression in the jejunum were improved 
in the Salmonella infected birds fed the diet supplemented with β-glucan. Tian et al. 
(2016) reported increased BW in broilers fed diet supplemented with 200 ppm of 91.5% 
pure yeast glucan between 21-42 days of age and on day 42 of the study. Improved 
phase FCR was also reported between 13-21 and 21-42 days of age, but not in the 
cumulative FCR. However, no significant improvement was observed in broiler 
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performance when those birds were challenged with Cp. Nevertheless, β-glucan 
improved villus height and crypt depth in challenged birds 7 days post challenge. The 
relative mRNA expression of endogenous antimicrobial peptides such as cathelicidin-1, 
cathelicidin-2, AvBD-1, AvBD-4, and AvBD-10 in the jejunum increased in glucan 
treatment birds post Cp challenge. Moreover, the Cp count in the cecum of infected 
glucan fed birds was decreased 14 and 21 days after challenge.  
This is the first time that chicken-specific peptide arrays were employed to study 
the influence of YCW or its components, MOS and glucan, on performance of starter 
broilers subjected to Cp challenge. The peptide arrays results demonstrated that Cp 
challenge impacted the immune and metabolic pathways in the intestine. A total of 459 
and 367 peptides in the jejunum and duodenum respectively that were significantly 
changed due to the Cp challenge. The YCW preparations or YCW components had 
different degree of influence on these peptides and this influence was also different in 
each part of the intestine. Whereas MOS and β-glucan treatments demonstrated only 
52.94 and 69.06% similarity compared to NCh-Cont in the jejunum, PYCW and 
SPYCW treatments were 80.61 and 74.07% respectively. In the duodenum section, the 
similarity coefficient was less noticeable for all treatments and the β-glucan treatment 
still had higher similarity coefficient (59.40%) than MOS treatment (33.97%). This 
PYCW was able to generate signaling neither of component (β-glucan or MOS) was able 
to generate alone. This may indicate that YCW components have synergetic effect and 
can have better influence on broiler performance than each component alone.   
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CHAPTER III 
ASSESSEMENT OF ALGAE BETA GLUCAN AND YEAST MANNAN ON 
BROILER PERFORMANCE UNDER CLOSTRIDIUM CHALLENGE 
 
Introduction 
Mannan and β-glucans are components of cell wall in many prokaryotic and 
eukaryotic organisms. β-glucans are polysaccharides consisting of glucose polymers and 
can be derived from different sources such as barley, fungi, yeast, bacteria, or algae. The 
structures of β-glucans are different between these sources (Jacob and Pescatore, 2014). 
While bacterial glucans consist of an unbranched 1,3-β-linked glycopyranosyl molecules 
backbone, yeast and fungal glucans have branched structures due to side chains joined to 
the backbone with 1,6-β-links. Glucans from algae (Euglena gracilis) are similar to 
bacterial glucan and consist of unbranched linear chains of glucose with 1,3-β-links. β-
glucans have been attracting interest from researchers and industry for their beneficial 
influences on human and animal health. Examples of those benefits include immune-
stimulatory, antimicrobial, anti-inflammatory, and antitumor properties (Zekovic et al., 
2005). 
Differences in the structure of β-glucans are linked to their different 
physiological functions (Jacob and Pescatore, 2014). Other factors also play significant 
roles in the biological activity of glucans such as degree of branching, solubility, 
molecular weight, polymer charge, and solution conformation (Zekovic et al., 2005). 
Most β-glucans that are used for research or commercial applications do not have high 
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purity (Novak and Vetvicka, 2009; Skov et al., 2012); they usually have 70% or less of 
purification, which might introduce other components to contribute to the immune-
stimulatory effects. This purity issue contributes to contradictions in reported findings 
and makes it challenging to understand the mechanism of action of β-glucans (Novak 
and Vetvicka, 2009; Skov et al., 2012).       
The Food and Drug Administration approved Euglena gracilis biomass 
containing 1,3-β-glucan as a generally recognized as safe (GRAS) product that can be 
used as a human food supplement (FDA, 2014). It was reported that 1,3-β-glucan 
derived from Euglena gracilis decreased mortality rate in mice infected with a lethal 
dose of E. coli (Richard et al., 2013) . In addition, specific (antibody titer) and non-
specific (natural killer cell activity and phagocytosis activity) immune responses were 
improved. The researchers suggested that 1,3-β-glucan can serve as an adjuvant to 
vaccines due to its ability to enhance antibody titer. Another study reported significant 
improvement in FCR and reduction in Eimeria oocytes shedding in broilers fed diets 
supplemented with 50% purified algae glucan and challenged with Eimeria (Tian et al., 
2016).  
A mannan oligosaccharide is a complex of glucomannoproteins that can be 
derived from the inner cell wall of fungi (mushroom or yeast). The mannan in YCW is 
found as a complex with protein called mannoproteins complex which comprises 40% of 
the YCW mass (Lipke and Ovalle, 1998). The YCW typically contains 15-30% MOS 
(ERUASYP, 2015). YCW-derived mannan is a linear polymer of mannose sugar 
consisting of an α 1-6 linked backbone and α 1-2 and 1-3 linked branches. Brewer’s 
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dried or baker’s yeasts are the main source of MOS for commercial applications. 
Because of the high cost associated with pure MOS, gums or YCW products which 
contain mannose-based carbohydrates, have been used in research and commercial 
applications as a source of MOS (Spring et al., 2000; Xiao et al., 2012). This research 
with gums and YCW products has linked MOS as the sole dependent variable, although 
it is not the only component in those MOS source products.  
One of the main effects that have been attributed to MOS is its ability to reduce 
the colonization of specific pathogenic microorganisms in the gut of the host. MOS 
inhibits colonization due to the attachment of bacteria exhibiting Type-1 fimbriae to the 
MOS which prevents bacterial attachment to the intestinal mucosa (Spring et al., 2000). 
In addition, supplementing broiler diets with YCW-derived MOS improves BW and 
FCR when the birds are subject to various environmental, nutritional, or pathological 
stressors (Benites et al., 2008; Hofacre et al., 2003; Sohail et al., 2012).  
In this study, a linear unbranched 1,3-β-glucan from Euglena gracilis with  ≥ 
98% purity and MOS from Saccharomyces cerevisiae with ≥ 98% purity were evaluated 
in two separate studies at three levels. The dietary influence of these highly purified 
products on broiler performance was investigated under pathogenic challenge with 
Clostridium perfringens after the birds were immunocompromised with a high dose of 
bursal disease vaccine.  
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Materials and Methods 
Two separate studies were conducted to evaluate different concentrations of a 
linear unbranched 1,3-β-glucan from Euglena gracilis (≥ 98% purity, Sigma-Aldrich, St. 
Louis, MO) or MOS from baker’s yeast Saccharomyces cerevisiae (≥ 99% purity, 
Sigma-Aldrich, St. Louis, MO). In each study, these levels where compared with 
commercial baker’s YCW (Safmannan, Phileo-Lesaffre Animal Care, Milwaukee, WI) 
product and two control groups either challenged with Cp or non-challenged (Ch-Cont 
and NCh-Cont). The Safmannan YCW is derived from baker’s yeast of Saccharomyces 
cerevisiae and contains 23.5% mannoproteins and 23.8% β-glucans. The levels of high 
purity MOS and β-glucans were calculated based on their equivalent content in 250 ppm 
of YCW and two additional levels approximately 50% more or less than the equivalent 
level.    
The studies were conducted at the Southern Plains Agricultural Research Center, 
Agricultural Research Service, United States Department of Agriculture and were 
approved by the Texas A&M Institutional Animal Care and Use Committee and the 
Animal Care and Use Committee (ACUC) at the Southern Plains Agricultural Research 
Center. 
Dietary treatments  
 In both studies, a basal corn/soy based broiler starter diet (Table 3.1) was 
formulated to meet the nutrient requirements suggested by the Ross-308 management 
handbook. The diet was then divided into five batches that included one batch for non-
challenge (T1) and challenge (T2) control, one for YCW (250 ppm; T3), and three other 
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treatments that are supplemented with different levels of either high purity glucan or 
MOS.  
The other three treatments in the β-glucan study included β-glucan at 30 ppm 
(T4), 60 ppm (T5), and 90 ppm (T6). For the MOS study, the other three treatments 
included MOS at 25 ppm (T4), 50 ppm (T5), and 100 ppm (T6).  
Animal husbandry 
 In each study, a total of 240 Ross 308 1-day-old chicks were distributed between 
two battery brooder units (48 pens; 5 birds/pen). Six treatments were randomly assigned 
to pens and each treatment had 8 replicates. All birds of 6 treatments were vaccinated 
with infectious bursal disease vaccine (Schering Plough Animal Health, Millsboro, DE) 
on day 10. The vaccine was administered at 10x the manufacturer’s recommended dose 
via the ocular route in order to immunocompromised the chicks (McReynolds et al., 
2004). On day 16 and 17, all treatments were challenged with Cp (107 cfu/mL, 3 ml oral 
gavage). Mortality within the first three days was replaced with new birds that had been 
fed the control diet. Feed and water were provided ad libitum. Feed and body weight 
data were recorded on days 1, 10, 16 and 21. The isolation and administration of Cp was 
performed as described previously in chapter II.  
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Table 3.1 Composition and nutrient content of the basal starter diet for algae beta 
glucan and yeast mannan oligosaccharides. 
Ingredient Amount 
Corn (%) 61.40 
Dehulled soybean meal (%) 32.18 
DL-Methionine 98% (%) 0.23 
Lysine HCl (%) 0.18 
Fat, blended animal/vegetable (%) 2.22 
Limestone (%) 1.44 
Mono-dicalcium phosphate (%)  1.55 
Salt (%) 0.51 
Trace minerals premix1 (%) 0.05 
Vitamin premix2 (%) 0.25 
Calculated nutrient content 
CP (%) 22.12 
ME (Kcal/kg) 3050 
Crude fat (%) 4.06 
Crude fiber (%) 2.15 
Calcium (%) 0.95 
Available phosphate (%) 0.45 
Sodium (%) 0.22 
Methionine (%) 0.56 
Lysine (%) 1.31 
1Trace minerals premix added at this rate yields (mg/kg): zinc, 60.0; manganese, 60.0. 
2Vitamin premix added at this rate yields (per kg): vitamin A, 11 kIU; vitamin D3, 3,850 IU; vitamin E, 
45.8 IU; menadione, 1.5 mg; B12, 0.017 mg; biotin, 0.55 mg; thiamine, 2.93 mg; riboflavin, 5.96 mg; d-
pantothenic acid, 20.17 mg; B6, 7.15 mg; niacin, 45.8 mg; folic acid, 1.74 mg; choline, 130.3 mg.   
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Statistical analysis  
 For each study, body weight, weight gain, and feed conversion ratio data were 
analyzed as a one-way ANOVA using the General Linear Model of SPSS software. Pen 
level was used as a block to control variation among groups of experimental units and 
the design of the experiment was an incomplete block. Means deemed significant at p ≤ 
0.05 were separated using a protected Duncan’s Multiple Range Test. 
 
Results and Discussion  
Two separate studies were conducted to evaluate the influence of different levels 
of highly purified unbranched 1,3-β-glucan from the algae Euglena gracilis (≥ 98.5 
purity) and MOS from baker’s yeast Saccharomyces cerevisiae (≥ 99.9% purity) on 
immunocompromised broiler performance under pathogenic challenge stress. The levels 
of both polysaccharides were compared with challenged and non-challenged control 
groups as well as challenged YCW treatment. In both studies, birds were 
immunocompromised on day 10 by administering the birds via ocular route with 10x the 
recommended level of commercial bursal disease vaccine (Fowler et al., 2015b; 
McReynolds et al., 2004). On day 16 and 17, birds in all treatments, except the non-
challenged control group, were subjected to Cp challenge by orally gavage the birds with 
3 ml of 107 cfu of Cp/mL.  
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For the glucan study, there were no significant differences between treatments in 
broiler performance on day 10 (Table 3.2), pre-vaccination (phase 1) . On day 16 (phase 
2), post-immunocompromising with bursal disease vaccine, all glucan treatments 
demonstrated the trend of improved performance. Specifically, birds fed a diet 
supplemented with 60 ppm of 1,3-β-glucan demonstrated significantly higher BW (542 
g) and WG (291 g) than birds in NCh-Cont (506 and 253 g, respectively) and Ch-Cont 
(497 and 249 g, respectively) treatments. No significant differences were observed in 
BW and WG between all glucan and YCW treatments. The birds in the 60 ppm glucan 
treatment had the lowest P-F:G (1.30) and C-F:G (1.26) and were significantly lower 
than BG-30 (1.38 and 1.32) and NCh-Cont (1.40 and 1.31). The P-F:G and C-F:G in 
BG-90 (1.35 and 1.29) were not significantly different from any of the other glucan 
treatments, either control groups, or YCW treatment (P-F:G = 1.33 and C-F:G = 1.29 for 
all treatments). No significant differences were observed in FCR or PI between 
treatments (Table 3.3).  
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Table 3.2 Effect of algae beta glucan levels on broiler performance on day 10 (pre-immunocompromised). 
 
Treatment group1 
NCh-Cont2 Ch-Cont2 YCW BG-30 BG-60 BG-90 
BW (g) 253 ± 12 248 ± 9 242 ± 18 256 ± 20 251 ± 17 252 ± 10 
WG (g) 208 ± 12 202 ± 9 197 ± 18 210 ± 20 207 ± 17 207 ± 10 
P-F:G 1.21 ± 0.03 1.20 ± 0.04 1.23 ± 0.04 1.25 ± 0.05 1.20 ± 0.03 1.21 ± 0.03 
FCR 0.99 ± 0.03 0.98 ± 0.04 1.00 ± 0.03 1.02 ± 0.04 1.00 ± 0.02 1.00 ± 0.03 
PI 204 ± 25 201 ± 17 192 ± 25 180 ± 31 204 ± 24 203 ± 21 
P-Mort 2.5%  2.5%  2.5%  12.5%  2.5%  2.5%  
Means ± SD  
1NCh-Cont = non-challenged control; Ch-Cont = challenged control; YCW = yeast cell wall (YCW) at 250 pm; BG-30, BG-60, and BG-
90 = 98.3% purified Algae β-glucan at 30, 60, and 90 ppm respectively.  
2NCh-Cont and Ch-Cont birds fed control diet, but differ on day 16 and 17 when Ch-Cont birds were challenged with Clostridium 
perfringens. 
P-F:G = phase feed:gain; PI = performance index; P-Mort = phase mortality. 
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Table 3.3 Effect of algae beta glucan levels on broiler performance on day 16 (pre-challenge). 
 
Treatment group1 
NCh-Cont2 Ch-Cont2 YCW BG-30 BG-60 BG-90 
BW (g) 506 ± 32bc 497 ± 21c 510 ± 36bc 532 ± 35ab 542 ± 37a 519 ± 16abc 
WG (g) 253 ± 24bc 249 ± 20c 267 ± 19abc 276 ± 28ab 291 ± 26a 267 ± 16abc 
P-F:G 1.40 ± 0.04c 1.35 ± 0.04abc 1.33 ± 0.03ab 1.38 ± 0.08bc 1.30 ± 0.05a 1.35 ± 0.04abc 
C-F:G 1.31 ± 0.03b 1.28 ± 0.03ab 1.29 ± 0.06ab 1.32 ± 0.05b 1.26 ± 0.03a 1.29 ± 0.02ab 
FCR 1.19 ± 0.04 1.16 ± 0.03 1.17 ± 0.05 1.20 ± 0.04 1.16 ± 0.03 1.17 ± 0.03 
PI 236 ± 30 237 ± 21 243 ± 34 215 ± 40 255 ± 22 245 ± 22 
P-Mort 0.0 0.0 0.0 3.1%  2.5%  0.0 
C-Mort 2.5%  2.5%  2.5%  15.0%  5.0  2.5%  
a-c Means ± SD within a row lacking a common superscript differ (P ≤ 0.05).  
1NCh-Cont = non-challenged control; Ch-Cont = challenged control; YCW = yeast cell wall (YCW) at 250 pm; BG-30, BG-60, and BG-90 = 98.3% 
purified Algae β-glucan at 30, 60, and 90 ppm respectively.  
2NCh-Cont and Ch-Cont birds fed control diet, but differ on day 16 and 17 when Ch-Cont birds were challenged with Clostridium perfringens. 
P-F:G = phase feed:gain; C-F:G = cumulative feed:gain; PI = performance index; P-Mort = phase mortality; C-Mort = Cumulative mortality. 
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On day 21 (phase 3, Table 3.4), post-challenge, the pathogenic challenge with Cp 
significantly impacted the Ch-Cont, as observed through lower BW (706 g) and WG 
(206 g) compared with NCh-Cont (783 and 277 g, respectively). Supplementing broiler 
starter diet with 1,3-β-glucan improved broiler resistance to the negative impact of Cp on 
BW and WG. The BW of the birds in BG-30 (784 g), BG-60 (777 g), and BG-90 (770 g) 
treatments was significantly higher than BW of Ch-Cont birds. However, no significant 
difference was observed in BW between these glucan treatments and NCh-Cont. The 
BW of YCW birds (752 g) was not significantly different from any of the glucan 
treatments or any of the control groups. A similar scenario was observed in WG except 
that birds in the BG-60 (235 g) treatment were not significantly different from Ch-Cont. 
However, no significant difference in WG was observed between BG-60 and both BG-
30 (253 g) and BG-90 (251 g), and the latter treatment had significantly higher WG than 
the Ch-Cont group. The WG of birds in the YCW treatment (243 g) was not significantly 
different from any of the glucan treatments or the control groups. No significant 
differences were noted in any of the other performance variables such P-F:G, C-F:G, 
FCR, PI, or mortality. The dose effect of BG on BW is presented in Figure 3.1 (BW was 
fit to the BG dose in a broken-line quadratic model; R2 = 0.288). The maximum dose of 
BG required to have maximum BW was calculated to be no more than 27.98 ppm.   
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Table 3.4 Effect of algae beta glucan levels on broiler performance on day 21 (post-challenge). 
 
Treatment group1 
NCh-Cont2 Ch-Cont2 YCW BG-30 BG-60 BG-90 
BW (g) 783 ± 61a 706 ± 51b 752 ± 70ab 784 ± 57a 777 ± 42a 770 ± 16a 
WG (g) 277 ± 34a 209 ± 38c 243 ± 41abc 252 ± 34ab 235 ± 20bc 251 ± 32ab 
P-F:G 1.54 ± 0.07 1.76 ± 0.19 1.67 ± 0.16 1.73 ± 0.12 1.80 ± 0.23 1.69 ± 0.15 
C-F:G 1.40 ± 0.02 1.42 ± 0.04 1.41 ± 0.06 1.45 ± 0.04 1.41 ± 0.05 1.42 ± 0.04 
FCR 1.31 ± 0.03 1.33 ± 0.04 1.32 ± 0.06 1.35 ± 0.03 1.33 ± 0.05 1.33 ± 0.04 
PI 256 ± 51 225 ± 31 248 ± 36 213 ± 45 235 ± 38 245 ± 23 
P-Mort 3.1%  2.5%  0.0 3.1%  5.5%  2.5%  
C-Mort 5.0%  5.0%  2.5%  17.5%  10.0%  5.0%  
a-c Means ± SD within a row lacking a common superscript differ (P ≤ 0.05).  
1NCh-Cont = non-challenged control; Ch-Cont = challenged control; YCW = yeast cell wall (YCW) at 250 pm; BG-30, BG-60, and BG-90 = 98.3% 
purified Algae β-glucan at 30, 60, and 90 ppm respectively.  
2NCh-Cont and Ch-Cont birds fed control diet, but differ on day 16 and 17 when Ch-Cont birds were challenged with Clostridium perfringens. 
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Figure 3.1 Effect of β-glucan dose on broiler body weight (BW). 
 
The β-glucan (BG) dose was calculated to be no more than 27.98 ppm to have maximum body 
weight (BW) on day 21.  
 
 
The results of highly purified MOS (≥ 99.9% purity) extracted from the baker’s 
yeast Saccharomyces cerevisiae study demonstrated no significant differences in starter 
broiler performance between treatments on day 10, pre-vaccination, or day 16, pre-
challenge (Tables 3.5 and 3.6).  
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Table 3.5 Effect of yeast mannan oligosaccharides levels on broiler performance on day 10 (pre-
immunocompromised). 
 
Treatment group1 
NCh-Cont2 Ch-Cont2 YCW MOS-25 MOS-50 MOS-100 
BW (g) 273 ± 9 264 ± 10 264 ± 7 259 ± 14 265 ± 6 270 ± 15 
WG (g) 230 ± 8 221 ± 11 221 ± 7 216 ± 14 222 ± 6 227 ± 14 
P-F:G 1.14 ± 0.02 1.13 ± 0.01 1.15 ± 0.03 1.17 ± 0.02 1.16 ± 0.03 1.16 ± 0.03 
FCR 0.95 ± 0.02 0.94 ± 0.01 0.96 ± 0.02 0.97 ± 0.03 0.97 ± 0.02 0.97 ± 0.02 
PI 241 ± 10 234 ± 11 225 ± 18 216 ± 21 229 ± 9 235 ± 19 
P-Mort 0.0 0.0 2.5%  2.5%  0.0 0.0 
Means ± SD.  
1NCh-Cont = non-challenged control; Ch-Cont = challenged control; YCW = yeast cell wall (YCW) at 250 pm; MOS-25, 50, and 100 = 99.8% purified 
baker’s yeast MOS at 25, 50 and 100 ppm respectively.  
2NCh-Cont and Ch-Cont birds fed control diet, but differ on day 16 and 17 when Ch-Cont birds were challenged with Clostridium perfringens. 
P-F:G = phase feed:gain; PI = performance index; P-Mort = phase mortality. 
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Table 3.6 Effect of yeast mannan oligosaccharides levels on broiler performance on day 16 (pre-challenge). 
 
Treatment group1 
NCh-Cont2 Ch-Cont2 YCW MOS-25 MOS-50 MOS-100 
BW (g) 544 ± 42 544 ± 35 534 ± 49 529 ± 35 521 ± 60 552 ± 36 
WG (g) 271 ± 44 280 ± 28 269 ± 47 270 ± 24 256 ± 59 282 ± 23 
P-F:G 1.46 ± 0.32 1.34 ± 0.04 1.45 ± 0.21 1.41 ± 0.06 1.49 ± 0.34 1.38 ± 0.06 
C-F:G 1.30 ± 0.12 1.25 ± 0.02 1.30 ± 0.08 1.30 ± 0.03 1.31 ± 0.10 1.28 ± 0.04 
FCR 1.19 ± 0.10 1.15 ± 0.02 1.20 ± 0.06 1.19 ± 0.02 1.20 ± 0.08 1.18 ± 0.03 
PI 266 ± 38 266 ± 33 244 ± 37 237 ± 43 245 ± 43 264 ± 35 
P-Mort 0.0 2.5%  2.5%  5.0%  2.5%  2.5%  
C-Mort 0.0 2.5%  5.0%  7.5%  2.5%  2.5%  
Means ± SD.  
1NCh-Cont = non-challenged control; Ch-Cont = challenged control; YCW = yeast cell wall (YCW) at 250 pm; MOS-25, 50, and 100 = 99.8% purified 
baker’s yeast MOS at 25, 50 and 100 ppm respectively.  
2NCh-Cont and Ch-Cont birds fed control diet, but differ on day 16 and 17 when Ch-Cont birds were challenged with Clostridium perfringens. 
P-F:G = phase feed:gain; C-F:G = cumulative feed:gain; PI = performance index; P-Mort = phase mortality; C-Mort = Cumulative mortality. 
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However, on day 21, post-challenge, significant differences were noticed in BW 
and WG of Ch-Cont and NCh-Cont birds (Table 3.7). The BW of Ch-Cont birds (784 g) 
was significantly lower than BW of NCh-Contr birds (844 g). Nevertheless, none of the 
treatments improved body weight significantly. The WG was significantly lower in Ch-
Cont (240 g) than NCh-Cont (300 g) treatment. Only the YCW treatment had WG (271 
g) that was not significantly different from the NCh-Cont or Ch-Cont group. No 
significant difference was reported in WG between MOS-25 (251 g), MOS-50 (254 g), 
or MOS-100 (230 g) treatments. In fact, only the MOS-100 treatment had significantly 
lower WG compared to NCh-Cont or YCW treatments.  
Although no significant difference was observed in P-F:G between treatments, 
MOS-100 birds had higher P-F:G (1.96) compared with NCh-Cont birds (1.51) at a p-
value of 0.055 (Table 3.7). This MOS treatment also had significantly higher C-F:G and 
FCR (1.45 and 1.37 respectively) than NCh-Cont (1.36 and 1.29) and Ch-Cont birds 
(1.38 and 1.30). However, there were no significant differences in C-F:G and FCR 
between MOS-25 (1.43 and 1.34), MOS-50 (1.42 and 1.33), YCW (1.44 and 1.35) and 
MOS-100 treatments. The birds in the MOS-50 treatment were as good as NCh-Cont 
with respect to FCR. There was no significant difference in PI between treatments for 
any of the MOS or YCW birds, but the NCh-Cont had significantly higher PI than all of 
these treatments. 
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Table 3.7 Effect of yeast mannan oligosaccharides levels on broiler performance on day 21 (post-challenge). 
 
Treatment group1 
NCh-Cont2 Ch-Cont2 YCW MOS-25 MOS-50 MOS-100 
BW (g) 844 ± 29a 784 ± 29b 798 ± 47b 780 ± 36b 775 ± 40b 782 ± 59b 
WG (g) 300 48a 240 ± 38bc 271 ± 29ab 251 ± 27bc 254 ± 44bc 230 ± 32c 
P-F:G3 1.51 ± 0.17 1.71 ± 0.22 1.78 ± 0.29 1.72 ± 0.18 1.74 ± 0.35 1.96 ± 0.34 
C-F:G 1.36 ± 0.03a 1.38 ± 0.05ab 1.44 ± 0.05bc 1.43 ± 0.03bc 1.42 ± 0.06bc 1.45 ± 0.07c 
FCR 1.29 ± 0.03a 1.30 ± 0.05ab 1.35 ± 0.05bc 1.34 ± 0.03bc 1.33 ± 0.06abc 1.37 ± 0.06c 
PI 281 ± 33a 251 ± 34ab 212 ± 56b 229 ± 44b 223 ± 45b 214 ± 54b 
P-Mort 5.0%  5.6%  15.7%  5.6%  12.5%  15.0%  
C-Mort 5.0%  7.5%  20.0%  12.5%  15.0%  17.5%  
a-cMeans ± SD within a row lacking a common superscript differ (P ≤ 0.05).  
1NCh-Cont = non-challenged control; Ch-Cont = challenged control; YCW = yeast cell wall (YCW) at 250 pm; MOS-25, 50, and 100 = 99.8% purified 
baker’s yeast MOS at 25, 50 and 100 ppm respectively.  
2NCh-Cont and Ch-Cont birds fed control diet, but differ on day 16 and 17 when Ch-Cont birds were challenged with Clostridium perfringens. 
3p-value = 0.055. 
P-F:G = phase feed:gain; C-F:G = cumulative feed:gain; PI = performance index; P-Mort = phase mortality; C-Mort = Cumulative mortality.
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In the glucan study, all levels of beta glucan demonstrated significantly improved 
broiler performance after immunocompromising on day 16 and after the Cp challenge on 
day 21. To the best of our knowledge, no published study has been conducted to assess 
the influence of the unbranched 1,3-β-glucan derived from Euglena gracilis (≥98.5 
purity) or MOS derived from Saccharomyces cerevisiae ( ≥ 99.9% purity) on broiler 
starter under Cp challenge. However, Levine et al. (2015) evaluated the anticoccidial 
influence of two commercial feed additives (Algamune™AM or Algamune™ ZPC) that 
contain 50% wt 1,3-β-glucan derived from  Euglena gracilis fed to broilers challenged 
with three Eimeria spp.. The authors reported significant improvement in FCR in birds 
that received 50 or 100 g/MT (25 or 50 ppm) of Algamune AM or 200 g/MT (100 ppm) 
of Algamune ZPC, which contains 2% zinc polysaccharide complex. In addition, 200 
g/MT of Algamune AM or 100 g/MT of Algamune ZPC significantly reduced oocytes 
per gram of fecal material. Several studies have been conducted to investigate the effects 
of β-glucan derived from Saccharomyces cerevisiae on broiler performance, gut 
histology, and the immune system (Cox et al., 2010a; Cox et al., 2010b; Tian et al., 
2016).  
Nevertheless, the structures of yeast glucan and algae glucan are not very similar 
since the former is composed of 1,3-β-links with 1,6-β-links branches. No significant 
influence was reported in broiler performance when yeast β-glucan was added to the 
diets at 200 or 1000 ppm with or without pathogenic stress (Cox et al., 2010a; Cox et al., 
2010b). However, Cox et al. (2010b) reported reduction in lesion scores due to Eimeria 
infection and enhancement in the immune response and improved T helper cells. Tian et 
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al. (2016) reported improved broiler performance, intestinal morphology, and immune 
response in broilers subjected to Eimeria challenge followed by Cp challenge.  
In MOS study, the results demonstrated no significant improvement in broiler 
performance when fed diet supplemented with three levels of high purity baker’s yeast 
MOS. However, a previous study reported improved performance in broilers fed 50 ppm 
MOS and subjected to Cp challenge (Chapter II). Other studies have reported improved 
broiler performance when fed diets supplemented with YCW derivatives as a source of 
MOS (Fowler et al., 2015a; Fowler et al., 2015b; M'Sadeq et al., 2015). However, MOS 
is not the only component of YCW, and results cannot be credited solely to MOS in 
these studies.  
In conclusion, the supplementation of broiler diets with high purity β-glucan 
extracted from Euglena gracilis may have beneficial effect on reducing the impact of Cp 
challenge. This ameliorative influence can be noticed at a level not higher than 25 ppm. 
Addition of high purity MOS extracted from cell wall of baker’s Saccharomyces 
cerevisiae to broiler feed did not demonstrate significant effect in elevating the impact of 
Cp challenge.              
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CHAPTER IV 
INFLUENCES OF SACCHAROMYCES CEREVISIAE-DERIVED Β-GLUCAN 
AND MANNAN ON BROILER PERFORMANCE 
 
Introduction  
β-glucan and mannan oligosaccharides (MOS) have been derived from different 
organisms such as yeast and algae. These two polysaccharides exist in different 
structures, depending on the links between the sugar polymers. Thus, their physiological 
functions can differ. This variation in their biological influence can cause different 
outcomes and interpretation in the literature. Understanding the effect of these two sugar 
polymers can be improved by using a single source to derive these polysaccharides.  
Yeast cell wall (YCW) from Saccharomyces cerevisiae is one of the main 
sources to extract MOS and β-glucan for laboratory and industry applications. The 
structure of YCW is composed mainly of branched 1,3-β-glucan with 1,6-β-links, 
mannoproteins complex, and a negligible component of chitin (Lipke and Ovalle, 1998). 
Commercial YCW contains 30-60% polysaccharides including mannan and β-glucan 
polymers, 15-30% proteins, 5-20% lipids, and a small portion of chitin (ERUASYP, 
2015). The MOS and most of the proteins are linked to form mannoprotein complexes.  
The use of YCW in food production animal feed and in poultry specifically as an 
alternative to antibiotic growth promotors has been under investigation for decades 
(Fowler et al., 2015a; Fowler et al., 2015b; Ghosh et al., 2007; Hashim et al., 2013; 
M'Sadeq et al., 2015; Sohail et al., 2012; Spring et al., 2000). Several benefits from 
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supplementing poultry diets with YCW have been reported such as improvements in 
performance, digestive tract integrity, health status, and resistance to specific pathogens.  
Since YCW products contain blends of polysaccharides (glucan and MOS) with 
significant amounts of proteins and lipids, it is not justified to describe YCW products as 
only MOS or only glucan. Therefore, this study aimed to study the influence of each 
polysaccharide component of YCW individually and in combination. To minimize the 
influence of different sources of MOS or glucan, these two components were derived 
from the same YCW product of Saccharomyces cerevisiae. The final purification of each 
component was obtained at a level that can practically be commercially available.  
 
Materials and Methods 
Dietary treatments  
 The YCW preparation was derived from baker’s Saccharomyces cerevisiae 
(Phileo-Lesaffre Animal Care, Milwaukee, WI). This YCW consist of 23.8% glucans, 
23.5% mannoproteins. The β-glucan was extracted from the same YCW and purified to 
be 50-55% β-glucan. The MOS was also derived from the same YCW to contain 50% 
mannoproteins.  
 A basal corn/soy based broiler starter diet (Table 4.1) was formulated to meet the 
nutrient requirements suggested by the Ross-308 management handbook. The diet was 
then divided into five batches that included one batch for non-challenge (T1) and 
challenge (T2) control, one for YCW (250 ppm; T3), MOS (117.3 ppm, T4), glucan 
(108.4 ppm, T5), and MOS+Glucan (117.3 + 108.4 ppm, respectively). The 
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concentrations of MOS and glucan were calculated to be equal to the amount of each one 
in the YCW treatment.  
Animal husbandry  
  A total of 240 Ross 308 (1-day-old) chicks were distributed between two battery 
brooder units (48 pens; 5 birds/pen). Six treatments were randomly assigned to pens, and 
each treatment had eight replicates. All birds of the six treatments were challenged with 
infectious bursal disease vaccine (Schering Plough Animal Health, Millsboro, DE) on 
day 10. The vaccine was administered at 10x the manufacturer’s recommended dose via 
the ocular route in order to immunocompromised the chicks (McReynolds et al., 2004). 
On day 16 and 17, all treatments were challenged with Clostridium perfringens (Cp) 
(107 cfu/mL, 3 mL oral gavage). Mortality within the first three days was replaced with 
new birds that had been fed the control diet. Feed and water were provided ad libitum. 
Feed and body weight data were recorded on days 1, 10, 16 and 21. The isolation and 
administration of Cp was performed as described previously in Chapter II.  
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Table 4.1 Composition and nutrient content of the basal starter diet for the yeast 
derived mannoproteins and β-glucan study. 
Ingredient Amount 
Corn (%) 61.40 
Dehulled soybean meal (%) 32.18 
DL-Methionine 98% (%) 0.23 
Lysine HCl (%) 0.18 
Fat, blended animal/vegetable (%) 2.22 
Limestone (%) 1.44 
Mono-dicalcium phosphate (%)  1.55 
Salt (%) 0.51 
Trace minerals premix1 (%) 0.05 
Vitamin premix2 (%) 0.25 
Calculated nutrient content 
CP (%) 22.12 
ME (Kcal/kg) 3050 
Crude fat (%) 4.06 
Crude fiber (%) 2.15 
Calcium (%) 0.95 
Available phosphate (%) 0.45 
Sodium (%) 0.22 
Methionine (%) 0.56 
Lysine (%) 1.31 
1Trace minerals premix added at this rate yields (mg/kg): zinc, 60.0; manganese, 60.0. 
2Vitamin premix added at this rate yields (per kg): vitamin A, 11 kIU; vitamin D3, 3,850 IU; vitamin E, 
45.8 IU; menadione, 1.5 mg; B12, 0.017 mg; biotin, 0.55 mg; thiamine, 2.93 mg; riboflavin, 5.96 mg; d-
pantothenic acid, 20.17 mg; B6, 7.15 mg; niacin, 45.8 mg; folic acid, 1.74 mg; choline, 130.3 mg.    
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The study was conducted at the Southern Plains Agricultural Research Center, 
Agricultural Research Service, United States Department of Agriculture and were 
approved by the Texas A&M Institutional Animal Care and Use Committee and the 
Animal Care and Use Committee (ACUC) at the Southern Plains Agricultural Research 
Center. 
Statistical analysis  
 Body weight (BW), weight gain (WG), phase and cumulative feed to gain ratios 
(P-F:G and C-F:G), feed conversion ratio (FCR), and performance index (PI) data were 
analyzed as a one-way ANOVA using the General Linear Model of SPSS software. 
Outlier values were excluded from treatments T2 and T3. Because of unequal numbers 
of replicates per treatment, type I error was not guaranteed, and thus Duncan’s and 
Tukey HSD tests were used to separate means.  
 
Results and Discussion  
 The results at day 10 are presented in table 4.2. On day 10, pre-vaccination 
stress, there was no statistically significant difference between treatments for any of the 
measured variables. On day 16, pre-challenge with Cp, there was no significant 
difference in BW, WG or PI. However, diets supplemented with YCW or any of its 
components individually or combined improved P-F:G significantly.  
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Table 4.2 Effect of yeast cell wall components on broiler performance on day 10 (pre-immunocompromised). 
 
Treatment group1 
NCh-Cont2 Ch-Cont2 YCW BG MOS BG+MOS 
BW (g) 265 ± 15 255 ± 18 260 ± 9 260 ± 14 249 ± 20 257 ± 10 
WG (g) 220 ± 15 210 ± 18 215 ± 9 214 ± 14 203 ± 20 212 ± 9 
P-F:G 1.19 ± 0.04 1.19 ± 0.02 1.19 ± 0.02 1.19 ± 0.03 1.19 ± 0.04 1.19 ± 0.03 
FCR 0.98 ± 0.02 0.98 ± 0.03 0.98 ± 0.02 0.98 ± 0.02 0.98 ± 0.03 0.98 ± 0.02 
PI 218 ± 22 215 ± 13 219 ± 8 219 ± 16 206 ± 32 210 ± 22 
P-Mort 2.5%  0.0 0.0 0.0 2.5%  2.9%  
Means ± SD.  
1NCh-Cont = non-challenged control; Ch-Cont = challenged control; YCW = yeast cell wall (YCW) at 250 pm; BG = 50-55% purified baker’s yeast β-
glucans at 108.4 ppm; MOS = 50% purified baker’s yeast mannoproteins at 117.3 ppm; BG+MOS = 108.4 ppm BG + 117.3 ppm MOS.  
2NCh-Cont and Ch-Cont birds fed control diet, but differ on day 16 and 17 when Ch-Cont birds were challenged with Clostridium perfringens. 
P-F:G = phase feed:gain; PI = performance index; P-Mort = phase mortality. 
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Table 4.3 Effect of yeast cell wall components on broiler performance on day 16 (pre-challenge). 
 
Treatment group1 
NCh-Cont2 Ch-Cont2 YCW BG MOS BG+MOS 
BW (g) 538 ± 40 510 ± 50 531 ± 34 540 ± 35 539 ± 31 549 ± 19 
WG (g) 273 ± 27 255 ± 32 271 ± 26 280 ± 27 291 ± 34 292 ± 14 
P-F:G 1.44 ± 0.07b 1.44 ± 0.09b 1.37 ± 0.03a 1.37 ± 0.05a 1.36 ± 0.02a 1.34 ± 0.03a 
C-F:G 1.32 ± 0.04b 1.32 ± 0.04b 1.29 ± 0.02ab 1.29 ± 0.04ab 1.28 ± 0.02a 1.27 ± 0.02a 
FCR 1.21 ± 0.02c 1.20 ± 0.03bc 1.18 ± 0.01ab 1.18 ± 0.02ab 1.17 ± 0.0a 1.17 ± 0.01a 
PI 249 ± 32 235 ± 36 257 ± 19 262 ± 21 262 ± 27 262 ± 29 
P-Mort 0.0 3.3%  0.0 0.0 0.0 0.0 
C-Mort 2.5%  3.3%  0.0 0.0 2.5%  2.9%  
a-cMeans ± SD within a row lacking a common superscript differ (P ≤ 0.05).  
1NCh-Cont = non-challenged control; Ch-Cont = challenged control; YCW = yeast cell wall (YCW) at 250 pm; BG = 50-55% purified baker’s yeast β-
glucans at 108.4 ppm; MOS = 50% purified baker’s yeast mannoproteins at 117.3 ppm; BG+MOS = 108.4 ppm BG + 117.3 ppm MOS.  
2NCh-Cont and Ch-Cont birds fed control diet, but differ on day 16 and 17 when Ch-Cont birds were challenged with Clostridium perfringens. 
P-F:G = phase feed:gain; C-F:G = cumulative feed:gain; PI = performance index; P-Mort = phase mortality; C-Mort = Cumulative mortality. 
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The birds in treatments YCW (T3), glucans (T4), mannoproteins (T5), and 
glucan with mannoproteins (T6) had significantly lower P-F:G (1.37, 1.37, 1.36, and 
1.34, respectively) than birds in both control groups, NCh-Cont (T1) and Ch-Cont (T2) 
(1.44 for both) (Table 4.3). In addition, treatments T5 and T6 had significantly lower C-
F:G (1.28 and 1.27) than T1 and T2, but not significantly lower than T3 and T4 (both 
1.29). The same scenario was observed in FCR for all treatments.  
 By day 21 (Table 4.4), post-challenge, the Cp challenge had impacted broiler 
performance. The average bird weight in the challenge control group was lower than the 
non-challenge control group by 92 g. The addition of YCW or its components to the 
broiler diets improved BW (P = 0.8). The birds in T6 were higher in BW than birds in 
T2 by 104 g (P = 0.075). WG in T2 (240 g) was significantly lower than in T1 (305 g). 
Birds in the T6 treatment demonstrated significantly higher WG (306) than the T2 
treatment, but not significantly different from other treatments. No significant difference 
was observed between T3 (285 g), T4 (252 g), and T5 (262), and these treatments were 
not significantly different from both control groups. No significant differences were 
observed between treatments in P-F:G, C-F:G, FCR, or PI. 
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Table 4.4 Effect of yeast cell wall components on broiler performance on day 21 (post-challenge). 
 
Treatment group1 
NCh-Cont2 Ch-Cont2 YCW BG MOS BG+MOS 
BW (g)3 843 ± 67 751 ± 71 816 ± 61 792 ± 75 801 ± 54 855 ± 65 
WG (g) 305 ± 31a 240 ± 43b 285 ± 43ab 252 ± 55ab 262 ± 44ab 306 ± 56a 
P-F:G 1.46 ± 0.10 1.64 ± 0.21 1.58 ± 0.18 1.73 ± 0.29 1.69 ± 0.19 1.59 ± 0.20 
C-F:G 1.38 ± 0.06 1.42 ± 0.07 1.38 ± 0.05 1.41 ± 0.06 1.40 ± 0.03 1.38 ± 0.07 
FCR 1.30 ± 0.04 1.33 ± 0.05 1.30 ± 0.04 1.33 ± 0.05 1.31 ± 0.02 1.30 ± 0.07 
PI 286 ± 42 246 ± 45 262 ± 51 234 ± 44 225 ± 55 243 ± 50 
P-Mort 0.0 0.0 6.7%  12.5%  16.3%  14.3%  
C-Mort 2.5%  3.3%  6.7%  12.5%  17.5%  17.1%  
a-cMeans ± SD within a row lacking a common superscript differ (P ≤ 0.05).   
1NCh-Cont = non-challenged control; Ch-Cont = challenged control; YCW = yeast cell wall (YCW) at 250 pm; BG = 50-55% purified baker’s yeast β-
glucans at 108.4 ppm; MOS = 50% purified baker’s yeast mannoproteins at 117.3 ppm; BG+MOS = 108.4 ppm BG + 117.3 ppm MOS.  
2NCh-Cont and Ch-Cont birds fed control diet, but differ on day 16 and 17 when Ch-Cont birds were challenged with Clostridium perfringens. 
P-F:G = phase feed:gain; C-F:G = cumulative feed:gain; PI = performance index; P-Mort = phase mortality; C-Mort = Cumulative mortality. 
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This study was conducted to assess each of the YCW (derived from 
Saccharomyces cerevisiae) components (MOS and glucan) individually or in 
combination and compare them to the original YCW (the same YCW that was used to 
extract these components) to eliminate the influence of different sources (Fowler et al., 
2015b). The levels of each component were calculated to be equivalent to the content of 
the corresponding part in the original YCW. The study was conducted in a Cp challenge 
model introduced on day 16 of age after birds were immunocompromised with 10x the 
recommended level of bursal disease vaccine (Fowler et al., 2015b; McReynolds et al., 
2004).  
The results demonstrated no significant difference between treatments in broiler 
performance on day 10. In previous studies conducted by our lab evaluating baker’s 
yeast cell wall products, no differences were observed in performance, especially when 
no stress was introduced at this early age. This is in agreement with other findings 
reported by other studies. M'Sadeq et al. (2015) reported that supplementation of YCW 
in broiler diets had no significant effect on broiler performance between 0 to 10 days of 
age. 
Administration of bursal disease vaccine 10x the recommended dose has been 
used to immunocompromised the birds to exaggerate the influence of Cp infection in 
broilers (McReynolds et al., 2004). The results of the current study demonstrated an 
improvement in feed utilization on day 16, after being immunocompromised on day 10 
and before the Cp challenge. This may suggest that YCW or its components mitigate the 
adverse effect of the high dose of vaccine.  
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Following the Cp challenge, on day 21, the non-challenged birds had 
significantly higher weight gain and improvement in BW compared to the challenged 
control. This is in agreement with studies described in previous chapters as well as other 
studies conducted by our lab (Fowler et al., 2015b). Supplementing the starter broiler 
diets with YCW or its components improved the ability of the birds to tolerate the 
impact of the Cp challenge. This improvement was significantly higher when the two 
components of YCW, mannoproteins purified at 50% and glucan at 50-55%, were 
combined together. The birds in this treatment demonstrated 104 g higher BW than birds 
in the challenged control group. Previous studies have reported improved broiler 
performance when fed diets supplemented with YCW after challenge with Cp (Fowler et 
al., 2015b; M'Sadeq et al., 2015). The results of the current study suggest that both 
mannoproteins and beta-glucans are equally important, perhaps even synergistic with 
respect to their effect on broilers undergoing immunogenic stress.  
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CHAPTER V  
PERFORMANCE OF BROILERS FED DIETS SUPPLEMENTED WITH TWO 
YEAST CELL WALL STRAINS USING TWO FEEDING STRATEGIES    
 
    Introduction  
In the poultry industry, it is common to reuse old litter for more than one year. 
However, the old litter provides a suitable environment for different kinds of living 
organisms, including pathogenic microbes such as coccidia. In addition, increased 
humidity and pH at warm temperatures enhance the proliferation of pathogenic bacteria 
in litter. The use of antibiotics at sub-therapeutic levels in animal feed as growth 
promotors improves animal performance and resistance to pathogens. The application of 
antimicrobials as growth promoters has been employed in the livestock industry for 
more than seventy years. However, concerns regarding development of antibiotic-
resistant bacteria in animals and potential transfer to humans have introduced the ban of 
these growth promotors and increased demand for alternatives.  
Supplementation of yeast cell wall products in animal feed has been reported as a 
potential alternative to antimicrobial growth promotors (Fowler et al., 2015a; Fowler et 
al., 2015b; Hashim et al., 2013; M'Sadeq et al., 2015; Sohail et al., 2012). YCW is 
capable of changing the microflora community structure in the gastrointestinal tract and 
changing the histological structure of the gut mucosa (M'Sadeq et al., 2015; Reisinger et 
al., 2012; Sohail et al., 2012). Pathogenic bacteria that express Type-1 fimbriae are 
diminished due to the ability of MOS in YCW to link to these types of pathogens such as 
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Salmonella (Spring et al., 2000). Antimicrobial peptides, important components of the 
innate immune response, express antimicrobial and immunomodulatory characteristics 
and are significantly upregulated in the jejunum due to the glucans of YCW (Tian et al., 
2016).  
Different sources of YCW, such as brewer’s and baker’s yeast, have been used in 
the industry. Differences in sources and levels could be one of the reasons different 
outcomes when YCW is added to animal diet (Fowler et al., 2015a). Studies conducted 
by our laboratory have demonstrated a quadratic effect of YCW on starter broiler 
performance under Cp challenge (Fowler et al., 2015b). These studies were conducted 
using battery cages that are not similar to commercial settings and cannot extend the 
study beyond 24 days because of size restriction. The purpose of the current study is to 
evaluate two sources of YCW from two different strains of Saccharomyces cerevisiae 
fed through two different strategies on full-term (1-42 days) broiler performance.  
 
Materials and Methods  
Dietary treatments  
  Two YCW products extracted from two different strains of Saccharomyces 
cerevisiae were used in this study to prepare the dietary treatments (Phileo-Lesaffre 
Animal Care, Milwaukee, WI). A basal corn/soy based broiler diet (Table 5.1) was 
formulated during each phase (starter, grower, and finisher) to meet the nutrient 
requirements suggested by the Ross-308 management handbook. The diet was then 
divided into five batches that included control (basal diet only, T1); basal diet with 250 
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ppm of strain 1 YCW in all three phases (T2); basal diet with strain 1 of YCW at 500 
ppm in starter phase, 250 ppm in grower phase, and 125 ppm in finisher phase (T3); 
basal diet with 250 ppm of strain 2 YCW in all three phases (T4); and basal diet with 
strain 2 of YCW at 500 ppm in the starter phase, 250 ppm in the grower phase, and 125 
in the finisher phase (T5).  
Animal husbandry  
 A total of 960 straight-run Ross-308 broiler chicks were randomly assigned to 60 
6’x 6’ floor pens with 16 birds/pen in a randomized block design with 12 pen replicates 
per treatment. The birds were placed in floor pens on used pine-shaving litter. The study 
utilized a full-term 42-d, 3-phase rearing program with a 21-d starter, 14-d grower, and 
7-d finisher phase. Mortality within the first three days was replaced with new birds that 
had been fed the control diet. Feed and water were provided ad libitum. Body weight 
(BW) and feed intake were collected for each phase, and mortality was monitored daily. 
The study was conducted at the Poultry Science Research Center and was approved by 
the Texas A&M Institutional Animal Care and Use Committee.  
Statistical analysis 
 The experiment was designed as a randomized block. Data were analyzed as a 
one-way ANOVA using the GLM procedure of SPSS. Means deemed significant at p ≤ 
0.05 were separated using a protected Duncan’s Multiple Range Test. 
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Table 5.1 Composition and nutrient content of the experimental basal diets. 
Ingredient Starter Grower Finisher 
Corn (%) 61.6 66.57 70.45 
Dehulled soybean meal 
(%) 
31.7 27.20 22.84 
Dl-Methionine 98% (%) 0.23 0.24 0.11 
Lysine HCl (%) 0.19 0.16 0.13 
Soybean oil (%) 2.20 2.21 3.15 
Limestone (%) 1.44 1.48 1.35 
Mono-dicalcium 
phosphate (%)  
1.55 1.39 1.38 
Salt (%) 0.51 0.41 0.14 
Trace minerals premix1 
(%) 
0.05 0.05 0.05 
Vitamin premix2 (%) 0.25 0.25 0.25 
Coban 90 0.05 0.05 - 
Sodium bicarbonate  - - 0.17 
Calculated nutrient content   
CP (%) 22.00 20.00 18.00 
ME (Kcal/kg) 3050 3100 3200 
Crude fat (%) 3.94 4.04 4.99 
Crude fiber (%) 2.14 2.02 1.90 
Calcium (%) 0.95 0.92 0.85 
Available phosphate (%) 0.45 0.41 0.40 
Sodium (%) 0.22 0.18 0.12 
Methionine (%) 0.56 0.54 0.39 
Lysine (%) 1.31 1.15 1.00 
1Trace minerals premix added at this rate yields (mg/kg): zinc, 60.0; manganese, 60.0. 
2Vitamin premix added at this rate yields (per kg): vitamin A, 11 kIU; vitamin D3, 3,850 IU; vitamin E, 
45.8 IU; menadione, 1.5 mg; B12, 0.017 mg; biotin, 0.55 mg; thiamine, 2.93 mg; riboflavin, 5.96 mg; d-
pantothenic acid, 20.17 mg; B6, 7.15 mg; niacin, 45.8 mg; folic acid, 1.74 mg; choline, 130.3 mg. 
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Results and Discussion  
 This study was conducted to assess the influence of supplementation with two 
YCW products from two different Saccharomyces cerevisiae strains. YCW 
supplementation was conducted in two different inclusion methods: supplementing diet 
with YCW at a consistent level, 250 ppm, during three rearing phases, or adding YCW 
to the diet at three levels starting with 500 ppm in the starter phase, 250 ppm in the 
grower phase, and 125 ppm in the finisher phase. The birds were placed in floor pens on 
used pine-shaving litter to mimic industry-type rearing conditions.  
 The results of starter phase are demonstrated in table 5.2. At the end of the 21-
day starter phase, birds that were fed diets supplemented with any of the YCW products 
at any of level performed better than the control birds. There was a 6.6 – 9.6% increase 
in BW for all of the YCW birds over the control birds. The BW of birds in T2, T3, T4, 
and T5 was significantly higher than BW of birds in the control group (819, 830, 807, 
812, and 757 g, respectively). The YCW treatments improved WG with 7.3 – 10.2% 
more gain than control birds. The WG of broilers in T2, T3, T4, and T5 treatments was 
significantly higher than the WG of broilers in the control (T1) group (776, 786, 765, 
768, and 713 g, respectively). There were no significant differences in P-F:G, C-F:G, 
FCR, or PI at day 21 of age.  
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Table 5.2 Effect of two different strains of yeast cell wall on broiler performance on day 21 (Starter Phase). 
 
Treatment group1 
T1 T2 T3 T4 T5 
BW (g) 757 ± 49b 819 ± 54a a830 ± 51 807 ± 38a 812 ± 39a 
WG (g) 713 ± 49b 776 ± 53a 786 ± 50a 765 ± 38a 768 ± 38a 
P-F:G 1.37 ± 0.17 1.37 ± 0.02 1.35 ± 0.03 1.35 ± 0.02 1.36 ± 0.02 
FCR 1.29 ± 0.15 1.30 ± 0.02 1.28 ± 0.02 1.28 ± 0.02 1.29 ± 0.02 
PI 266 ± 40 285 ± 21 292 ± 23 281 ± 17 284 ± 16 
P-Mort 0.52%  0.0 0.52%  1.62%  0.0 
a-bMeans ± SD within a row lacking a common superscript differ (P ≤ 0.05).   
1T1 = control; T2 = strain 1 yeast cell wall (YCW) at 250 pm all phases; T3 = strain 1 YCW at 500, 250, & 125 ppm starter, grower, & finisher phases 
respectively; T4 = strain 2 YCW at 250 ppm all phases; T5 = strain 2 YCW at 500, 250, & 125 ppm starter, grower, & finisher phases respectively.  
P-F:G = phase feed:gain; PI = performance index; P-Mort = phase mortality. 
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At the end of the grower phase (Table 5.3), on day 35, the trends of improved 
BW and WG were similar to the starter phase, and additional improvement was noticed 
in other performance variables such as P-F:G, C-F:G, FCR, and PI. At that age, all birds 
except control birds were fed diets supplemented with the same inclusion rate of YCW 
at 250 ppm. The supplementation of broiler diets with any of the YCW products 
significantly improved BW. The increase in average BW for phase 2 was 5.4 – 7.8% 
more in YCW treatments than with control. The average BW of the birds in T1 was 2140 
g, T2 was 2284 g, T3 was 2307 g, T4 was 2296 g, and T5 was 2256 g. The WG was 
significantly higher in T2, T3, T4, and T5 than control (1465, 1478, 1489, 1445, and 
1384 g, respectively). Birds in T4 demonstrated significant improvement in P-F:G (1.55) 
and FCR (1.45), and C-F:G (1.48) was numerically lower (P = 0.057) than all other 
treatments. Performance index was significantly improved in all YCW treatments (409-
422) compared to control (389).  
At the end of the finisher phase (Table 5.4), at 41-days-old, birds in any of the 
YCW treatments had significantly higher BW and PI than control birds. The average 
BW in control birds was 2875 g, significantly lower than the average BW of T2, T3, T4, 
and T5 birds (3032, 3073, 3045, and 3013 g, respectively). The PI of the control group 
(415) was significantly lower than the PI values of T2, T3, T4, and T5 (440, 447, 442, 
and 433, respectively). There were no significant differences between treatments in WG, 
P-F:G, C-F:G, or FCR. 
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Table 5.3 Effect of two different strains of yeast cell wall on broiler performance on day 35 (Grower phase). 
 
Treatment group1 
T1 T2 T3 T4 T5 
BW (g) 2140 ± 81b 2284 ± 102a a2307 ± 95 2296 ± 85a 2256 ± 88a 
WG (g) 1384 ± 55b 1465 ± 63a 1478 ± 67a 1489 ± 60a 1445 ± 68a 
P-F:G 1.59 ± 0.05b 1.59 ± 0.03b 1.59 ± 0.03b 1.55 ± 0.02a 1.60 ± 0.03b 
C-F:G2 1.52 ± 0.06b  1.51 ± 0.02b 1.50 ± 0.02b 1.48 ± 0.01a 1.52 ± 0.02b 
FCR 1.49 ± 0.06b 1.49 ± 0.02b 1.48 ± 0.02b 1.45 ± 0.01a 1.49 ± 0.02b 
PI 389 ± 25b 419 ± 21a 422 ± 23a 422 ± 21a 409 ± 20a 
P-Mort 0.52%  0.0 0.52%  0.52%  1.0%  
C-Mort 1.0%  0.0 1.0%  2.1%  1.0% 
a-bMeans ± SD within a row lacking a common superscript differ (P ≤ 0.05).   
1T1 = control; T2 = strain 1 yeast cell wall (YCW) at 250 pm all phases; T3 = strain 1 YCW at 500, 250, & 125 ppm starter, grower, & finisher phases 
respectively; T4 = strain 2 YCW at 250 ppm all phases; T5 = strain 2 YCW at 500, 250, & 125 ppm starter, grower, & finisher phases respectively. 
2P-value = 0.057. 
P-F:G = phase feed:gain; C-F:G = cumulative feed:gain; PI = performance index; P-Mort = phase mortality; C-Mort = Cumulative mortality. 
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Table 5.4 Effect of two different strains of yeast cell wall on broiler performance on day 42 (Finisher phase). 
 
Treatment group1 
T1 T2 T3 T4 T5 
BW (g) 2875 ± 75b 3032 ± 110a a3073 ± 126 3045 ± 91a 3013 ± 103a 
WG (g) 733 ± 39 745 ± 34 763 ± 45 747 ± 39 754 ± 28 
P-F:G 1.98 ± 0.11 2.00 ± 0.08 1.97 ± 0.05 1.99 ± 0.07 1.97 ± 0.06 
C-F:G 1.63 ± 0.05  1.63 ± 0.02 1.62 ± 0.02 1.61 ± 0.02 1.63 ± 0.02 
FCR 1.61 ± 0.05 1.61 ± 0.02 1.60 ± 0.02 1.58 ± 0.02 1.61 ± 0.02 
PI 415 ± 17b 440 ± 20a 447 ± 24a 442 ± 15a 433 ± 19a 
P-Mort 0.0 0.5%  0.0 0.0 0.52%  
C-Mort 1.0%  0.5%  1.0%  2.1%  1.6%  
a-bMeans ± SD within a row lacking a common superscript differ (P ≤ 0.05).   
1T1 = control; T2 = strain 1 yeast cell wall (YCW) at 250 pm all phases; T3 = strain 1 YCW at 500, 250, & 125 ppm starter, grower, & finisher phases 
respectively; T4 = strain 2 YCW at 250 ppm all phases; T5 = strain 2 YCW at 500, 250, & 125 ppm starter, grower, & finisher phases respectively. 
P-F:G = phase feed:gain; C-F:G = cumulative feed:gain; PI = performance index; P-Mort = phase mortality; C-Mort = Cumulative mortality. 
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The results of this study demonstrated improved performance in broilers reared 
on a reused pine shavings floor and fed diets supplemented with any of the YCW 
products using any of the two supplementation programs. It was reported in previous 
studies that doses of YCW have a quadratic effect on starter broiler BW subjected to Cp 
challenge (Fowler et al., 2015b). The optimum YCW inclusion rate was calculated to be 
295 ppm. Fowler et al. (2015a) reported no significant difference in broiler performance 
between control corn/soybean diet and YCW treatments at 250 ppm during the starter 
phase when birds were raised on fresh pine shavings. However, this study reported a 
significantly higher WG in birds fed YCW at 250 ppm than control birds during the 
grower phase. It was also reported that YCW derived from Saccharomyces cerevisiae  
had no significant effect on broiler performance at 24 or 35 days old compared to control 
when new hard wood litter was used to cover the floor pens (M'Sadeq et al., 2015). In 
this study, the YCW was added to the diets at 800, 400, 200 ppm during the starter, 
grower, and finisher phases, respectively. Nevertheless, YCW did improve BW on day 
24 and 35 when birds were challenge with attenuated Eimeria spp oocysts on day 9 and 
Cp on days 14 and 15. The findings of the current study suggest that YCW can improve 
broiler performance when raised on reused floor beds that can introduce different 
pathogenic challenges.          
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CHAPTER VI 
SUMMARY  
 
The latest joint report from the Centers of Diseases Control and Prevention and 
the U.S. Department of Health and Human Services reported that improperly prepared 
chicken meat is the second-greatest source of foodborne illness outbreaks after fish in 
the United States. The use of antibiotic growth promotors (AGPs) in poultry feed since 
the 1940’s has not only improved the performance of the birds, but has also controlled 
the virulence of several pathogenic challenges at the farm level which undoubtedly has 
to some extent helped to limit foodborne illnesses as a result of poultry consumption.  
One of the pathogenic challenges that can be somewhat controlled by AGPs is necrotic 
enteritis (NE) caused by Clostridium perfringens (Cp). The deleterious outcomes of NE 
have dramatic financial impacts on the poultry industry because of the chronic negative 
influence on bird performance. This impact on performance is a consequence of poor 
digestion and absorption of the nutrients and thus low FCR in the long term.  
There is growing concern with the employment of antibiotics at sub-therapeutic 
levels in animal feed due to reports of transferable antibiotic resistant bacteria from food 
animals to humans. This concern is amplified with medically important growth 
promotors. In addition, the FDA has issued a Guidance for Industry and proposed a 
Veterinary Feed Directive that will take effect at the end of 2016. These two documents 
restrict poultry and livestock producers from non-medical application of antimicrobials 
that are considered medically important to humans. In addition, the recent report of the 
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National Action Plan for Combatting Antibiotic Resistant Bacteria indicated that one of 
their goals to slowing the emergence of antibiotic resistance and preventing its spread is 
by ceasing the use of medically important antibiotics in food animal industry at sub-
therapeutic levels. These challenges have increased the efforts to invent and/or develop 
new antibiotic alternatives that are capable of improving or at least maintaining 
performance of livestock animals while at the same time boosting their resistance to 
pathogenic challenges.  
Mannan oligosaccharides and β-glucan are major components of the cell wall of 
many living organisms such as yeast and algae. Macrophages and other phagocytes 
express different pathogen recognition receptors (PRRs) such as glucan and mannose 
receptors. Those PRRs recognize specific structures known as MAMPs or PAMPs that 
are found on several microorganisms but not on host cells. Therefore, YCW, which is a 
rich source of mannan and β-glucans, has demonstrated promising positive influence on 
animal performance and health.  
The literature has reported contradictory results from the use of YCW, MOS, and 
β-glucan. These conflicts in reported outcomes could be the result of using YCW 
preparations that are not purely MOS or glucans and assuming that only one of those 
components is the main influencer. In addition, different purification levels can be found 
for YCWs in general or their components. Moreover, the MOS and glucans can be 
derived from many sources beside yeast such as algae, mushroom, and gum.   
For this dissertation, the purification level of YCW preparations demonstrated 
significant impact on broiler performance with the more highly purified YCW product 
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able to alleviate the impact of Cp on challenge birds. In addition, the metabolic pathways 
in birds challenged with Cp and fed purified YCW were more likely to be similar to the 
metabolic pathways of non-challenged birds.  
The highly purified β-glucan derived from Euglena gracilis demonstrated 
significant influence on broiler performance when birds were challenged with Cp. It was 
noticed that addition of this product at levels no greater than 30 ppm can be sufficient to 
achieve maximum performance in starter broilers subjected to Cp challenge. However, 
highly purified MOS derived from Saccharomyces cerevisiae did not significantly 
improve performance of Cp challenged starter broilers.  
In the third study, chapter 4, Both MOS and β-glucan preparations were extracted 
from the YCW of Saccharomyces cerevisiae and purified to 50 – 55%. Neither one of 
these preparation demonstrated significant effect on Cp challenged starter broilers. 
However, addition of both preparations to the starter broiler diets at levels similar to 
their proportions in commercial YCW product improved broiler performance. This may 
indicate that these two components of YCW have a synergistic effect.     
The inclusion of any of the two different products of YCW derived from two 
different strains of Saccharomyces cerevisiae in full-term broiler diets either at 250 ppm 
continuously, or starting with 500, 250 and then 125 ppm during the finisher phase 
demonstrated similar influence on broiler performance. However, adding 250 ppm 
throughout the rearing period could be more economically feasible since less of the 
YCW would be included.    
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In conclusion, YCW purification plays important role in improving broiler 
performance response to this supplement. The components of YCW, MOS and β-glucan, 
appear to work more effectively when combined. The β-glucan derived from algae, 
Euglena gracilis, demonstrated significant outcomes in starter broiler performance that 
was not reported in yeast β-glucan. This could be as a result of the structure of algae 
glucan used in this study that was unbranched 1,3-β glucan.    
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